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ABSTRACT 
 
 Researchers predict a world population of approximately 9.5 billion people by the year 
2050.  Current resources, including the amount of meat that is produced, would not be able to 
sustain that population.  Therefore, the current dissertation research was completed to assist in 
improving reproductive efficiency.  A third of pregnancies are “lost”, or spontaneously aborted 
with unknown reason(s).  Therefore, research has been directed towards improving reproductive 
efficiency, especially in regards to proper ovarian function in both pregnant and non-pregnant 
females. 
Numerous factors influence reproduction including hormones, growth and angiogenic 
factors, nutritional plane, and supplements such as arginine (Arg), a semi-essential amino acid 
and precursor for proteins, polyamines, and nitric oxide (NO).  Nitric oxide is a reactive gas 
molecule made naturally in the body and is critical for angiogenesis, which is the development of 
blood vessels, generally capillaries, from pre-existing blood vessels to allow for blood flow to 
specific tissues.  During a female’s reproductive cycle, certain reproductive tissues undergo rapid 
changes including vascular development and regression, and tissue growth and regression.  One 
of those tissues, the corpus luteum (CL), is critical for pregnancy as the tissue produces 
progesterone (P4), a pregnancy maintenance hormone.  Therefore, the objective of this research 
was to investigate how manipulation of the NO system via Arg supplementation to nutritionally 
compromised ewes impacts ovarian function and endocrine activity in non-pregnant sheep. 
Keywords: Nutrition, Ewe, Progesterone, Nitric Oxide
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CHAPTER 1: LITERATURE REVIEW 
 
Nutritional Effects on Reproduction 
 
Nutritional Effects on Metabolic Hormones 
Hormones are molecules released by a specific group of cells within an endocrine system 
that are capable of influencing changes in another group of cells.  Hormones, along with the 
nervous system, control the body's responses to internal and external stimuli and are carried to 
their target cells in the bloodstream (Nussey and Whitehead, 2001).  Hormones have the ability 
to cause a physiological change within the body by binding at the target cell, which has produced 
a specific hormone receptor (Neave, 2008).  When a hormone binds to its corresponding 
receptor, it causes a conformational change in the receptor's shape; the shape change allows the 
receptor to fit with other cell molecules in a way it previously could not, thus initiating new 
activities in the cell (Neave, 2008). While a hormone reaches the majority of tissues and cells 
within the body, only some cells produce corresponding receptors, which are then sensitive to a 
specific hormone’s actions.  
 Insulin is a peptide hormone produced by beta cells within the pancreas and regulates the 
metabolism of carbohydrates and fats through increasing the absorption of glucose from blood 
plasma to skeletal muscle; it also inhibits the production of glucose by the liver (Sonksen and 
Sonksen, 2000).  Insulin is produced and stored in the body as a hexamer (a unit composed of six 
insulin molecules), with the active form being a monomer (Mayer, 2007).  The hexamer is an 
inactive form but has long-term stability, while the biologically active form is a monomer 
(Mayer, 2007).  Specific transporter proteins in myocyte and adipocyte cell membranes allow 
glucose from the blood to enter a cell; these transporters being directly under the control of 
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insulin (De Meyts, 2004).  Low blood insulin concentrations will prevent glucose from entering 
the cells, while higher concentrations will allow for cell glucose entry.  Activation of insulin 
receptors causes internal cellular mechanism changes that directly affect the cellular uptake of 
glucose (De Meyts, 2004).  Specifically, when insulin binds the extracellular portion of the alpha 
subunit of the insulin receptor, it causes a conformational change, activating the kinase domain 
residing on the beta subunit within the intracellular receptor.  The activated kinase domain 
autophosphorylates tyrosine residues on the C-terminus of the receptor, resulting in an increase 
in glucose 4 transporters (GLUT 4) present in the cell membrane (Huang et al., 2004).  A 
negative energy balance has been associated with changes in metabolic hormones, including 
insulin concentrations; specifically, a negative energy balance is associated with 
hypoinsulinemia (Kiyma et al., 2004; Wade and Jones, 2005; Ferraretto et al., 2014).  
Oppositely, positive energy balance has been reported to result in increased insulin in ruminant 
species (Armstrong et al., 2003; Grazul-Bilska et al., 2012; Kaminski et al., 2015), as well as 
glucose uptake.  Insulin is responsible for regulating over 100 genes, most at the level of 
transcription, in many different organs including the ovary (Poretsky et al., 1999).  Insulin 
receptors are widely expressed on several ovarian cells and tissues, including granulosa, theca, 
and stromal tissues (Poretsky et al., 1984, 1999; Hernandez et al., 1992; Samoto et al., 1993), 
leading some researchers to postulate that insulin has a direct effect on ovarian development 
and/or function (Samoto et al., 1993).  Moreover, in vitro studies have demonstrated that insulin 
stimulates ovarian steroidogenesis by granulosa and theca cells, increasing androgens, estrogens, 
and progesterone production in tissues from women (Willis et al., 1996; McGee et al., 1996), and 
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sows (Barbieri et al., 1983, 1994), and that this increase is mainly mediated by changes in insulin 
receptor expression (Poretsky et al., 1999).   
 Leptin is a metabolic protein consisting of 167 amino acids (Baratta, 2002) produced 
predominantly by white adipose tissue, as well as brain (Burguera et al., 2000), skeletal muscle, 
mammary epithelial cells (Casabiell et al., 1997), bone marrow, and ovaries (Ryan et al., 2002).   
After leptin is secreted, it circulates in free-form, or with carrier proteins (Sinha et al., 1996), to 
cross the blood brain barrier (BBB), wherein it binds to the hypothalamic leptin receptors and to 
neuropeptide Y (NPY) neurons in the arcuate nucleus, providing information about the energy 
stores within the body (Meister et al., 2000; Sahu et al., 2004).  Leptin signaling functions as a 
feedback mechanism to the brain to regulate food intake and maintain body weight 
(Pelleymounter et al., 1995).  Short-term (12 h) or long-term (two to eight weeks) of overfeeding 
results in an increase in adipocyte leptin expression, as well as circulating leptin in healthy 
humans and other species (Kolaczynski et al., 1996; Spicer et al., 2001; Chilliard et al., 2005; 
Kiani et al., 2013;  Kaminski et al., 2015).  Leptin is also involved with adaptation to energy 
deprivation (Klok et al., 2007).  Specifically, fasting for three days results in a significant 
decrease in peripheral leptin concentrations (Kolaczynski et al., 1996; Weigle et al., 1997).  
Leptin is also involved with pubertal development and reproductive functions (Hamm et al., 
2004).  Mice with two defective Ob genes, the gene responsible for expressing leptin, not only 
have metabolic issues such as being obese, but also are infertile, have fewer ovarian follicles 
(Barash et al., 1996), impaired folliculogenesis, and increased granulosa cell apoptosis (Ryan et 
al., 2002; Hamm et al., 2004).   
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Insulin-like growth factor 1 (IGF-1) is a protein consisting of 70 amino acids produced 
predominately by the liver as an endocrine hormone.  Approximately 98% of IGF-1 is bound to 
one of six proteins, is regulated by insulin, and its primary action is mediated by binding to either 
its specific receptor (IGF-1R) or the insulin receptor (Mayer, 2007).  The IGF-1R is considered 
the more physiologically active receptor as it binds IGF-1 at a significantly higher affinity 
(Huang et al., 2004).  By binding its corresponding receptor, IGF-1 activates the AKT signaling 
pathway, stimulating cell growth and proliferation, as well as inhibiting programmed cell death 
(Huang et al., 2004).  It should be noted that IGF-1 is also the primary activator for growth 
hormone (GH), which is produced form the anterior pituitary gland (Blogowska et al., 2001).  
Once released into the blood stream, GH stimulates the liver to produce IGF-1, which in turn 
stimulates body growth.  While IGF-1 is produced throughout life, the highest rates are during 
pubertal growth and the lowest concentrations are produced during infancy and old age (Scarth, 
2006).  While an increase in protein consumption increases IGF-1 concentrations in humans, it 
appears to be independent of total caloric consumption (Scarth, 2006).  Other factors that 
influence IGF-1 production include genetics, stress levels, body mass index, nutritional plane 
(Scarth, 2006), and insulin (Poretsky et al., 1988).  Moreover, dietary restriction can rapidly 
reduce IGF-1 concentrations, and in vivo studies with rats and women demonstrated that 
hyperinsulinemia upregulates IGF-1R expression in the ovaries (Poretsky et al., 1988; Samoto et 
al., 1993).  On the other hand, overfeeding enhances serum IGF-1 concentrations in several 
species including sheep (Armstrong et al., 2001, 2003; Ginther et al., 2004, Adamiak et al., 2005; 
Kaminski et al., 2015). There is a functional link between IGF-1 and ovarian function, as IGF-1R 
and FSH receptor co-localize in both small and preovulatory follicle granulosa cells (Zhou et al., 
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1997).  In granulosa cells, IGF-1 enhances FSH actions by mechanisms that are not entirely clear 
(Orly, 2000).  Mice that are not capable of producing IGF-1 or its receptor exhibit severe ovarian 
follicular growth retardation (Baker et al., 1996; Burks et al., 2000; Richards et al., 2002).   
Nutritional Effects on Reproductive Hormones  
 Nutrition has a significant impact on reproductive hormones, ovarian follicle and corpora 
lutea (CL) function, oocyte competence, and fertility (McEvoy et al., 1995; Wrenzycki et al., 
2000; Kwong et al., 2000; Boland et al., 2001; Armstrong et al., 2001, 2003; Da Silva et al., 
2002).  An animal, when in a negative energy balance, must use its own body energy stores (as 
opposed to energy from food intake) in an effort to reverse the energy deficit, resulting in 
negative effects on both the hypothalamic-pituitary level as well as the reproductive system 
(Scaramuzzi et al., 2006).   
While follicle stimulating hormone (FSH) and luteinizing hormone (LH) are critical 
signaling hormones for follicular growth, ovulation, and luteinization, their actions are directly 
dependent upon other signaling pathways, including those of metabolic hormones like insulin 
(Poretsky et al., 1999; Richards et al., 2002) and leptin (Ryan et al., 2002; Hamm et al., 2004).  
Tatman et al. (1990) reported that the LH content within the pituitary was lower in ewes with 
decreased body condition scores (BCS).  Moreover, researchers have observed suppressed LH 
mRNA expression in underfed ewes (Kile et al., 1991).  While long-term feed restriction can 
cause anestrous in cattle due to insufficient circulating LH (Rhodes et al., 1995, 1996), short-
term effects cause either decreased preovulatory surges of LH (Kiyma et al., 2004) or no changes 
to LH concentrations (Abecia et al., 1995).  Conversely, researchers have also reported no 
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differences in LH concentrations in ewes of high and low nutritional plane during the weeks 
prior to mating (Rhind et al., 1985).    
Serum FSH concentrations were greater in chronically underfed heifers compared to 
controls (Rhodes et al., 1996; Bossis et al., 1999; Mackey et al., 2000).  Researchers postulate 
the different responses of LH and FSH concentrations are due to differences in storage of the 
hormones (Diskin et al., 2003).  Specifically, LH is produced and stored in the pituitary, while 
very little FSH is stored (McNeilly et al., 1995) and once synthesized, is constitutively secreted 
(Farnworth et al., 1995).  Regardless of hormonal storage, there is little evidence to suggest that 
negative energy balance has any direct effects on ovine ovarian function that are independent of 
its effects on the hypothalamo-pituitary axis (Lozana et al., 2003; Kiyma et al., 2004).  Several 
researchers have suggested and agreed on the “ovarian hypothesis” that altered nutrition first 
influences metabolic hormones, such as insulin or leptin, and secondarily, the ovary by 
modulating gonadotropin action (Beitz et al., 1985; Downing and Scaramuzzi, 1991; Diskin et a., 
2003), having effects on FSH and LH.   
Serum concentrations of estradiol (E2) have been reported to be lower in fasted ewes 
when compared to control ewes (Adams et al., 1997; Kiyma et al., 2004) and rats (Oukonyong et 
al., 2000).  Grazul-Bilska et al (2012) demonstrated greater serum E2 concentration in underfed 
than overfed FSH-treated ewes.  The decreased E2 concentrations following short-term feed 
deprivation may be due to reduced ovarian follicular development caused by suppressed serum 
gonadotropin concentrations (Gougeon, 1996).  Additionally, Adams et al. (1994) reported not 
only that undernourished ewes exhibited less E2 secretion, but a simultaneous reduced metabolic 
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clearance rate of the hormone, which may explain the overall lower peripheral concentration 
observed in nutritionally restricted ewes (Adams et al., 1994, 1997).   
A direct relationship between nutritional plane and P4 concentrations have been reported 
in ewes and heifers, with overfed ewes having greater P4 when compared to control or underfed 
ewes (Kaminski et al., 2015; Armstrong et al., 2006).  However, an inverse relationship between 
nutritional plane and P4 have also been demonstrated, with decreased nutrition resulting in 
increased P4 concentrations in ewes (Williams and Cumming, 1982; Parr et al., 1982; Rhind et 
al., 1989; Kiyma et al., 2004), sows (Dyck et al., 1980; Miller et al., 1999), and cows (Donaldson 
et al., 1970; Jordan and Swanson, 1979; Rabiee et al., 2001; Ferraretto et al., 2014).  The effect 
of decreased nutritional quantity causing increased peripheral P4 concentrations has been 
hypothesized to be due to multiple reasons including P4 metabolism and clearance rate (Kiyma 
et al., 2004; Parr et al., 1993; Smith et al., 2006).  There are conflicting reports as to whether 
greater CL number can produce greater P4 concentrations.  For example, Amiridis et al. (2002) 
demonstrated a linear relationship between CL number and P4 concentrations, while Lamond et 
al. (1972) reported increased CL numbers do not have greater plasma P4 concentrations in sheep.  
In our studies, a greater number of CL was associated with greater serum P4 concentration 
(Grazul-Bilska et al. 2007; Kaminski et al. 2015), Furthermore, it has been suggested that 
animals provided inadequate nutrition may have prolonged P4 catabolism (Kiyma et al., 2004).  
In addition, nutritional changes have altered hepatic metabolism of steroids, slowing clearing 
rates in livestock (Parr et al., 1993; as reviewed by Smith et al., 2006).  Lastly, the catabolism of 
adipose tissues releases previously stored P4 into the circulatory system in cows (i.e. animals 
losing weight, and therefore metabolizing fat tissues, may actually have an increase in peripheral 
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P4 as it is freed from fat) (Hamudikuwanda et al., 1996).  It should be noted that increased P4 
concentrations in underfed animals is not likely due to increased adrenal synthesis of P4, as 
serum concentrations of cortisol from differing nutritional treatments have not been observed 
(Kiyma et al., 2004).         
Positive energy balance due to excess dietary intake also causes changes in production 
and functions of reproductive hormones.  Parr (1992) demonstrated that overfed ewes had lower 
peripheral P4 concentrations, and attributed the change to an increase in P4 clearance rate rather 
than to decrease P4 secretion rates.   In cows fed increased dry matter intake (DMI), 
Sangsritavong et al. (2002) observed increased blood flow to the liver, which was associated 
with increased metabolic clearance of P4 and E2 and, therefore, decreased peripheral P4. 
Nutritional Effects on Ovarian Function 
While early studies focused primarily on nutritional effects to the hypothalamic-pituitary 
axis, more recent investigations have hypothesized that nutritional changes and, therefore, 
changes to metabolic hormones have a direct effect on the ovary (Coop et al., 1966; Parr, 1992; 
Gong et al., 2002; Viñoles et al., 2010).  In fact, direct effects of nutrition on ovarian function 
including effects on folliculogenesis (Coop et al., 1966; Diskin et al., 2003; Viñoles et al., 2010), 
oocyte quality, ovulation rates, luteal function, and fertility in several species have been reported 
(Coop et al., 1966; Botkin et al., 1988; Dunn and Moss, 1992; O’Callaghan and Boland, 1999; 
Papadopoulos et al., 2001; Borowczyk et al., 2006; Grazul-Bilska et al., 2012). It should be noted 
that differences caused by positive or negative energy balances can occur before any detectable 
changes to the body, such as changes in BW or BCS (Scaramuzzi et al., 2006).   
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Numerous studies have demonstrated that increased dietary energy and/or protein, BW, 
and/or BCS resulted in increased ovarian follicular recruitment resulting in enhanced number of 
visible follicles in sheep (Coop et al., 1966; Xu et al., 1989; Abecia et al., 2006).  Conversely, 
other researchers have demonstrated that overfeeding and underfeeding did not affect the number 
of both small and large follicles when compared to controls in sheep (Abecia et al., 1995, 1997; 
Borowczyk et al., 2006; Grazul-Bilska et al., 2012).  However, nutrient restriction has been 
associated with reduced ovulation in FSH-treated and not treated ewes (Lassoued et al., 2004) 
and in ewes treated with FSH (Yaakub et al., 1997).  Nutrient restriction three to six days prior to 
ovulation has also been associated with reduced dominant follicle size (Murphy et al., 1991) and 
ovulations for prostaglandin-treated heifers (Mackey et al., 1999).   
Researchers have reported specific times during the mature ewe’s life wherein nutritional 
effects are more critical (Robinson et al., 2006).  For example, if nutrient restriction occurs when 
follicles are emerging from the primordial pool and become committed to growth, which occurs 
six months prior to the breeding season, it results in reduced ovarian follicle numbers, and 
therefore ovulation, at mating time (Robinson et al., 2006).   
Nutritional Effects on Oocyte Quality 
  The effects of plane of nutrition on oocyte quality have been evaluated in both non-
stimulated and FSH-stimulated in sheep and cows.  However, nutrient intake effects on oocyte 
quality are frequently contradictory, demonstrating no effects, or either negative or positive 
effects in ruminant and other species (McEvoy et al., 1995; O’Callaghan et al., 2000; Boland et 
al., 2001; Lozano et al., 2003; Peura et al., 2003; Grazul-Bilska et al., 2012).   
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While high nutritional plane feeding has been reported to increase oocyte quality in 
spontaneously ovulating ewes, the opposite was true in FSH-treated animals, which have a lower 
ovulation rate compared with ewes offered diets of twice maintenance energy requirements 
(Yaakub et al., 1997).  Overfeeding FSH-treated ewes resulted in negative effects on oocyte 
quality as determined by decreased in vitro cleavage rates (Papadopoulos et al., 2001; Lozano et 
al., 2003; Grazul-Bilska et al., 2012).  While reasons for these changes are not well understood, it 
has been postulated that an excess of rumen degradable components cause elevated ammonia 
concentrations in follicular fluid (FF), which cause a detrimental environment for the oocyte 
(Rooke et al., 2004).   
Yaakub et al. (1997) reported interchromatin granule detachment from the nucleus in 
oocytes from non-stimulated underfed ewes, which may account for decreased cleavage rates.  
Researchers have also reported underfeeding having a negative impact on oocyte quality in 
superovulated ewes, resulting in lower oocyte cleavage rates after IVF when compared to 
controls (Yaakub et al., 1997; Snijders et al., 2000; Borowczyk et al., 2006; Grazul-Bilska et al., 
2012).  In dairy cows, Jorritsma et al. (2004) observed that greater concentrations of non-
esterified fatty acids (NEFA), which are elevated in underfed animals, reduced granulosa cell 
proliferation and delayed oocyte maturation as well.  Conversely, other researchers have reported 
a greater proportion of ova were considered viable in underfed FSH-treated ewes when 
compared to those derived from overfed ewes (McEvoy et al., 1995; Lozano et al., 2003).  
Differences in reported results could be due to different species or breeds utilized, plane of 
nutrition and/or length of nutritional treatments.     
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  Excess or reduction in caloric intake result in changes to endogenous lipid content within 
the oocyte (Metwally et al., 2007; Robker et al., 2011).  Mammalian oocytes have an 
intracellular lipid reserve that, while varying between species and not completely understood in 
terms of function, appears to be vital for early embryonic development (Dunning and Robker, 
2012).  Lipid droplets, which serve as triglyceride storage sites, are composed of a neutral lipid 
core enclosed by a phospholipid monolayer and an outer coat layer that regulates droplet size 
(Dunning and Robker, 2012).  The accumulation of lipids within the oocyte is thought to provide 
sustaining energy to a preimplantation embryo (Ferguson and Leese, 2006).  Triglyceride stores 
decrease throughout in vitro oocyte maturation in cows (Ferguson and Leese, 1999) and sows 
(Sturmey and Leese, 2003).  Therefore, it has been postulated that a greater cytoplasmic store of 
lipids might be advantageous to the oocyte as it undergoes high-energy demanding processes, 
such as fertilization and cleavage (Castaneda et al., 2013).  On the other hand, it has been 
reported that the accumulation of excess intracellular lipids within cells leads to increased 
concentrations of free fatty acids, which are subject to both oxidative damage and highly reactive 
lipid peroxidases.  These damages can ultimately lead to intracellular organelle damage, 
predominantly to the endoplasmic reticulum (ER) and mitochondria (Borradaile et al., 2006).  
Exposure of the ER to high concentrations of free fatty acids causes alterations in ER function 
and lead to the production and accumulation of unfolded proteins (Diakogiannaki et al., 2008), 
which then activates the unfolded protein uptake response (UPR).  The UPR includes cell arrest, 
protein degradation (Rutkowski et al., 2004), and if not corrected, can lead to cell apoptosis 
(Kaufman et al., 1999).  Furthermore, studies in obese female mice have demonstrated that 
obesity induces slower blastocyst development and an altered trophectoderm to inner cell mass 
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(ICM) ratio (Minge et al., 2008).  These oocytes also contain increased lipid content, 
mitochondrial activity changes, and show signs of ER stress (Wu et al., 2010).  However, it 
remains unclear as to whether nutritional effects on oocytes is a result that occurs during 
folliculogenesis or is instigated immediately before conception (Dunning and Robker, 2012).     
Nutritional Effects on Early Embryonic Development 
Fertilization rates and early embryonic development are affected by the mother’s 
nutritional plane.  Nutritional effects may be one of many factors leading to the 20 to 30% of 
early pregnancy loss observed in ewes (Edey, 1969).  For nutrient restricted ewes, an increase in 
unfertilized ova (Rhind et al., 1989), reduced development to morula and blastocysts after IVF 
(Rhind et al., 1989; Abecia et al., 1995; Borowczyk et al., 2006; Grazul-Bilska et al., 2012), and 
increased fetal and neonatal mortality in sheep (Wallace et al., 2004) have been reported.  
Additionally, others have shown that underfeeding resulted in decreased embryonic development 
during the first two weeks post-fertilization in sheep (Parr et al., 1987; Abecia et al., 1997).   
Overfeeding has also resulted in decreased cleavage rates after IVF in ewes 
(Papadopoulos et al., 2001; Borowczyk et al., 2006; Grazul-Bilska et al., 2006; Zhu et al., 2010).  
McEvoy et al. (1995) reported that excessive feeding in superovulated ewes resulted in a reduced 
number of embryos developing to the blastocyst stage.  Furthermore, Abecia et al. (2006) 
hypothesized that “overfeeding during follicle recruitment and oocyte maturation imparts a 
legacy of embryonic loss and developmental retardation.”  While reasons for seemingly 
contradictory results are not readily evident, inconsistent results discussed here may be due to 
differences in experimental design, such as duration of over/underfeeding, diet composition, time 
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of nutritional treatment, breed utilized and/or culture conditions (Botkin et al., 1988; Grazul-
Bilska et al., 2012)  
Angiogenesis 
Angiogenic Process 
The organization of vascular network structures has enthralled scientists for many years 
(Carmeliet, 2000; Conway et al., 2001) and Aristotle first described it as such: 
“…the system of blood vessels in the body may be compared to those of water-courses which 
are constructed in gardens: they start from one source, or spring, and branch off into 
numerous channels, and then into still more, and so on progressively, so as to carry a supply 
to every part of the garden”.   
The body’s vessel formation and function, however, is obviously much more complex.  
The three main processes that initially form and later remodel blood vessels are termed 
vasculogenesis, angiogenesis, and arteriogenesis (Carmeliet, 2004).  Vasculogenesis describes 
the de novo blood vessel formation throughout embryogenesis, while angiogenesis refers to new 
capillary branching and remodeling from preexisting vessels (Risau and Flamme, 1995).  
Arteriogenesis denotes existing arterial reconstruction to increase luminal diameter in response 
to increased blood flow (Heil et al., 2006).  In healthy adults, angiogenesis is infrequent, 
occurring during tissue repair, some pathological conditions and within the female reproductive 
system (D’Amore and Klagsbrun, 1989; Reynolds et al., 2002).   
Vascular changes are possible due to cell differentiation, proliferation, migration and 
tissue remodeling to form new blood vessel structures (Folkman and Klagsburn, 1987; Risau, 
1997).  Angiogenesis (Fig. 1.1) first commences with vasodilation, an expansion of the blood 
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vessel, due to increased nitric oxide (NO) (Carmeliet, 2000) and an increase in vascular 
permeability (Distler et al., 2002).   
 
Figure 1.1. Creation of new blood vessels by angiogenesis via endothelial cell migration, 
proliferation, and creation of new basement membranes.   
 
The increase in NO transcriptionally upregulates vascular endothelial growth factor 
(VEGF) expression (Kimura et al., 2000).  In addition, before endothelial cells can migrate from 
existing blood vessel, they must be loosened from their vessel matrix.  The preexisting vessel’s 
organized destruction is regulated by increased angiopoietin (ANGPT) 2 expression.  Similar to 
ANGPT1, ANGPT2 binds Tie (tyrosine kinase with immunoglobulin and epidermal growth 
factor homology domain) 2 but, instead of causing phosphorylation, ANGPT2 simply blocks 
ANGPT1-mediated Tie2 receptor activation.  This change is involved in detaching smooth 
muscle cells (SMC) and loosening the matrix (Maisonpierre et al., 1997; Gale and Yancopoulos, 
1999).  Enhanced VEGF expression increases blood vessel permeability, allowing extravasation, 
or leakage, of plasma proteins (Senger et al., 1983; Dvorak et al., 1995), which pass through the 
blood vessel and are responsible for laying down a basic “scaffold” for the new blood vessel.  
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However, permeability has to be tightly controlled, as excessive vascular leakage can have 
negative implications, such as blood vessel collapse (Carmeliet, 2000).  The redistribution of 
platelet endothelial cell adhesion molecule (PECAM)-1 and ANGPT 1 helps modulate the blood 
vessel wall permeability (Eliceiri et al., 1999; Gale and Yancopoulos, 1999).  ANGPT1 is a Tie2 
receptor ligand and an inhibitor of vascular permeability, tightening preexisting vessels 
(Thurston et al., 2000).  Several matrix metalloproteinase (MMP) partake in angiogenesis by 
degrading matrix molecules and by initiating growth factors action within the extracellular 
matrix (Coussens et al., 1999; reviewed in Nelson et al., 2000).  Once the vessel matrix is more 
permeable and has been infiltrated with plasma proteins, local vessel conditions are favorable for 
cell proliferation and migration of endothelial cells from the capillary walls (Nguyen et al., 2001; 
Distler et al., 2002).  At this phase, capillary tubules migrate towards angiogenic stimuli 
(Folkman and Haundenschild, 1979; Gross et al., 1983).  Blood vessels are then able to “sprout”, 
or expand, and during further vascular maturation, capillaries can fuse to form larger vessels like 
arterioles and venules (Karamysheva, 2008).            
Ovarian Angiogenesis   
Ovarian structures, such as follicles and the corpus luteum (CL), undergo a cyclic growth 
and regression, and depend upon the continuous hemodynamic changes (Collins et al., 1991; 
Redmer and Reynolds, 1996; Reynolds et al., 2000; Reynolds and Redmer, 2001).   
Follicular development is contingent upon adequate microvasculature (Hirshfield, 1991), 
as both nutrients and hormones are supplied through diffusion from blood vessels of the thecal 
layer to the granulosa cell layer, under control of gonadotropins and other factors leading to 
follicular development.  In fact, follicles with reduced DNA synthesis of follicular endothelial 
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cells are associated with reduced vascular development and atresia (Greenwald, 1989). After the 
primordial germ cells (PGC) undergo mitosis, they form oogonium and then primary oocytes.  
While the majority of ovarian follicles recruited into a growing pool will undergo atresia, a few 
antral follicles (the number varying among species) will continue to develop and become 
preovulatory follicles.  Development and growth of a follicle is dependent upon healthy 
vascularization.  Capillaries of the theca interna form a vast network, known as the capillary 
wreath, which exists close to the basement membrane.  While blood flow decreases at the apex 
of the Graafian follicle, it actually increases around the base of the follicle (Brannstrom et al., 
1998), facilitating follicular rupture and ovulation.  As ovulation nears, the wreath capillaries 
enlarge and form wide sinusoids (Ellinwood et al., 1979; Reynolds et al., 2005).  Researchers 
have postulated that changes in capillary wreath structure allow for permeability of the granulosa 
cell layer for capillary invasion after ovulation, an event necessary to support quick CL growth 
(Redmer et al., 2001).   
Ovulation is dependent upon the change of blood flow to ovarian follicles.  Ovulation has 
been compared with an inflammatory response, due to the active follicular hyperemia, increase 
in prostaglandin release, and synthesis of the hyaluronic-rich extracellular matrix that occurs 
(Richards et al., 2008).  Together, the oocyte and surrounding granulosa cells ovulate from the 
antral follicle.   
After ovulation, the vasculature system is rapidly growing in the developing CL 
(Dharmarajan et al., 1985; Redmer et al., 2001).  The angiogenic activity in the developing CL 
includes destruction of the basement membrane that separated the granulosa and theca cell layers 
of the Graafian follicle, followed by capillary development into the formerly avascular granulosa 
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cell layer (Meyer and McGeachie, 1988; Reynolds et al., 2000; Reynolds et al., 2005).  This 
capillary growth is extensive and necessary for providing crucial nutrients to luteal cells, and 
allowing for efficient outflow of P4 produced and secreted by luteal cells; because of this, the CL 
receives the majority of the ovarian blood supply (Reynolds et al., 1986; Niswender and Nett, 
1988; Reynolds et al., 1994).  Maturation of the CL, during the luteal phase, includes 
stabilization and maturation of blood vessels.  During this time, pericytes from the theca 
capillaries migrate into the granulosa cell area, and multiply so that a great percentage of mature 
CL vessels contain pericytes (Goede et al., 1998; Reynolds and Redmer, 1999).    
The length of angiogenic processes within CL varies among species, but the growth 
phase lasts eight to ten days in ruminants (Reynolds et al., 2002).  The majority, between 50 to 
85%, of cellular proliferation that occurs within the developing CL occurs within the 
microvascular structures (Reynolds et al., 1994, 2002; Christenson and Stouffer, 1997) and the 
CL pericytes and endothelial cells encompass about 40-70% of the total  cell population 
(Reynolds et al., 2000; Reynolds et al., 2002).  Since the majority of the luteal call compostion 
are vascular cells, the majority of steroidogenic cells in the mature CL are in contact with one or 
more capillaries (Dharmarajan et al., 1985; Redmer et al., 2001).   
Prostaglandin F2α (PGF2α) is the main luteolytic hormone, with the main action being to 
decrease ovarian blood flow and control luteolysis (Knickerbocker et al., 1988; Niswender et al., 
2000).  There is evidence that capillary endothelial cells are involved in the luteolytic cascade 
(Smith and Meidan, 2014) described in more detail in several reviews (Townson, 2006; 
Skarzynski and Ferreira‐Dias, 2008; Miyamoto et al., 2010).  PGF2α enhances permeability of 
endothelial cell and inhibits cell proliferation within luteal tissues (Davis, 2010).  Binding of 
 18 
 
 
PGF2α to specific membrane receptors on the luteal cell results in rapid activation of 
phospholipase C, the release of intracellular Ca2+ from the endoplasmic reticulum (ER), and the 
activation of phosphokinase C (PKC) (Davis and Rueda, 2002).  When PGF2α is administered in 
vivo, an acute increase in blood flow is observed between 30 minutes and 2 hours post-injection 
(Acosta et al., 2002), suggesting the initial increase in blood flow induced by PGF2α injection 
during mid-luteal cycle commences the luteolytic cascade (Acosta and Miyamoto, 2004).  
Administration of PGF2α also induced cyclooxygenase COX-2 expression between one and four 
hours post-injection in the ewe (Tsai and Wiltbank, 1997), and is hypothesized to be partially 
responsible for the increase in CL blood flow during mid-cycle PGF2α release (Acosta and 
Miyamoto, 2004).  Shortly after PGF2α administration and blood flow increase, capillary 
alterations appear followed by a decrease in P4 secretion and CL volume (Acosta and Miyamoto 
et al., 2004).   
Regulation of Ovarian Angiogenesis and Angiogenic Factors 
For angiogenesis to successfully occur, a complex array of highly regulated angiogenic 
factors interact with several cell and tissue types (Goede et al., 1998).  Angiogenic factors are 
responsible for stimulating angiogenesis within growing tissues and several are present within 
the ovary including members of VEGF, ANGPT and FGF families of growth factors (Reynolds 
et al., 1994; Goede et al., 1998; Neufeld et al., 1999; Grazul-Bilska et al., 2001). 
Vascular Endothelial Growth Factor 
While there are several molecules known to serve as angiogenesis regulators, not all are 
specific to vascular endothelial cells and only some are able to directly influence endothelial 
cells in culture (Karamysheva et al., 2008).  One critical signaling cascade for angiogenic 
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regulation involves vascular endothelial growth factor (VEGF).  The homodimeric glycoprotein 
of 45 kD is a potent mitogen for vascular endothelial cells (Leung et al., 1989; Geva and Jaffe, 
2000) and also increases vessel permeability (Senger et al., 1983; Ferrara and Davis-Smith, 
1997).  Five known VEGF isoforms differ in molecular weight and binding abilities varying 
amongst isoform.  Two isoforms are bound in the extracellular matrix (ECM), while the other 
three forms are secreted (Park et al., 1993).  Growth factors from the VEGF family such as 
VEGF or PGF exert cellular biological effects by binding to specific receptors, FLT (FMS-like 
tyrosine kinase) 1, KDR and FLT4 located on endothelial cell membranes (Davis et al., 1996). 
These receptors belong to the receptor tyrosine kinase (RTK) family of proteins (as reviewed by 
Karamysheva, 2008).   
In vivo studies have demonstrated that VEGF stimulates angiogenesis in the ovaries 
including the CL (Leung et al., 1989; Redmer et al., 1996, 2001).  VEGF expression is not only 
great during CL vascular development in ovine tissues (Redmer et al., 1996; Redmer et al., 
2001), but have also observed that VEGF remains at greater expression during the mid-luteal 
phase when compared to early-and mid-luteal phases, suggesting VEGF is also a survival factor 
for newly developed blood vessels (Alon et al., 1995; Moreira et al., 2007).  Thecal pericytes 
expressing VEGF invade the granulosa cell layer within hours of ovulation (Redmer et al., 
2001), appearing to be one of the major angiogenic factors in the female reproductive organs 
(Reynolds et al., 2002).  Moreover, thecal-derived perivascular cells may direct the developing 
vascular system within the early CL due to high VEGF expression (Reynolds et al., 2000; 
Redmer et al., 2001).  In cultured ovine luteal cells, VEGF mRNA expression is increased by 
30% after LH treatment (Toutges et al., 1999).  In addition, treatment with an antibody to VEGF 
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neutralizes approximately 65% of the endothelial chemotactic activity of ovine (Reynolds et al., 
2000) and primates (Fraser et al., 1999) CL.      
Several studies have demonstrated the expression and importance of VEGF within the 
female reproductive system, for angiogenic and other processes.  During follicular recruitment 
and development, VEGF expression from theca cells in growing follicles is increased by 
gonadotropins and leads to increased vascular network in theca layer (Mattioli et al., 2001).  As 
folliculogenesis continues, FF, which is a derivative from plasma, accumulates.  As theca cell 
VEGF secretion increases, vascular permeability also increases (Levin et al., 1998), resulting in 
further accumulation of antral FF (Kamat et al., 1995).  Mattioli et al. (2001) observed that 
follicles with greater E2 concentrations also had greater VEGF concentrations, and suggested 
increased vascular permeability induced by VEGF facilitates the delivery of androgen 
precursors, such as selected lipids, to theca cells.  Theca androgens are then aromatized in the 
avascular granulosa cell layer and form E2.  Further evidence of the importance of VEGF in 
folliculogenesis and steroidogenesis include the observation that administration of a VEGF 
antibody to monkey follicles at the periovulatory stage prevents follicle development and E2 
synthesis (Zimmermann et al., 2001).  Additionally, reduced follicular vascularity and DNA 
synthesis are observed in follicles undergoing atresia (Greenwald, 1989) and may actually 
mediate follicular selection, as dominant follicles have more vascular theca (Zeleznik et al., 
1981; Redmer et al., 1996).    
Redmer et al. (2001) reported that pericytes produce and secrete VEGF in sheep CL, and 
CL growth and P4 production depends on proper blood supply stimulated by VEGF (Ferrara et 
al., 1998).  In fact, administering an antibody to VEGF, and thereby neutralizing VEGF activity, 
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resulted in suppressed luteal endothelial cell proliferation, restricted development of 
microvasculature, and decreased P4 production in rats (Ferrara et al., 1998) and monkeys (Fraser 
et al., 1999, 2000). 
While VEGF is a potent angiogenic factor, its effects are known to be different in 
developing versus adult organisms.  In fact, the importance of VEGF and its corresponding 
receptors for vascular development has been well documented in genetically engineered mice 
lacking these proteins (Fong et al., 1995; Shalaby et al., 1995; Carmeliet et al., 1996).  Gerber et 
al. (1999) demonstrated that VEGF inhibition via administration of mFLT (1-3)-IgG, a soluble 
VEGF receptor chimeric protein, in newborn mice pups but not in adult mice caused insufficient 
maturation of blood vessels and significant apoptotic changes.  Loss of VEGF dependence may 
result from development and involvement of pericytes (Gerber et al., 1999).  As mentioned 
previously, VEGF also increases blood vessel permeability (Senger et al., 1983; Dvorak et al., 
1995).  Under hypoxic conditions, VEGF mRNA expression is increased (Dor et al., 2001), and 
is also increased by other angiogenic factors, such as fibroblast growth factors (FGF).   
Placental Growth Factors 
Placental growth factor (PGF) was the second member of the VEGF family discovered 
and, as the name refers,t was originally cloned from a human placenta cDNA library (Maglione 
et al., 1991).  Similar to other members of the VEGF family, isoforms exist due to alternative 
splicing (Maglione et al., 1993; Ferrara et al., 2003); it is secreted as a glycosylated homodimer.  
As for receptor binding, PGF binds VEGFR with almost native affinity (Keyt et al., 1996).         
The involvement of PGF in angiogenesis processes has been confirmed through gain-of-
function research and was first reported as a pro-angiogenic factor by Ziche et al. (1997).  In 
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transgenic mice overexpressing PGF in epidermal layers, increased number and branching of 
dermal blood vessels with both a significant increase of smooth muscle surrounding vessels and 
also vascular leakiness has been obsterved (Odorisio et al., 2002).  Gain and loss of function 
experiments have also demonstrated that PGF stimulates angiogenesis in multiple ways.  By 
acting on growth, migration, and survival of endothelial cells, PGF can stimulate vessel growth 
directly (Ziche et al., 1997; Carmeliet et al., 2001; Fischer et al., 2007).  Placental growth factor 
also partakes in blood vessel maturation by increasing the proliferation and recruitment of SMC 
and supporting fibroblast proliferation (Yonekura et al., 1999; Bellik et al., 2005).   
Within the adult female reproductive tract, PGF is expressed in the ovary, including 
granulosa cells, and is present in FF (Hou et al., 2014; Tal et al., 2014).  VEGF and PGF 
concentrations within FF are positively correlated with follicular size, and may mediate ovarian 
follicle angiogenesis and dominant follicle selection, as well as contribution to oocyte 
development in women undergoing IVF (Hou et al., 2014).  The PGF is expressed in human 
endothelial cells (Yonekura et al., 1999).  In adult PGF knock out (KO) mice, impairment of 
angiogenesis and arteriogenesis during pathological conditions, such as tumor growth, have been 
reported (Carmeliet et al., 2001).  In a double KO for PGF and endothelial nitric oxide synthase 
(eNOS), loss of function has also demonstrated the importance of PGF (Papapetropoulos et al., 
1997).  This enzyme and its product, NO, are a downstream target for VEGF and the mice have 
hind-limb ischemia and increased death rates.  This mouse model represented the first 
experimental animal model of defective angiogenesis demonstrating the interactions between 
PGF and eNOS (Gigante et al., 2006).  Further, gain and loss of function studies have 
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demonstrated that PGF promotes angiogenesis by acting directly on endothelial cells, stimulating 
their growth, migration, and survival (Ziche et al., 1997; Adini et al., 2002; Fischer et al., 2007).  
Angiopoietins  
While the VEGF signaling system initiates vascular development and remodeling, 
ANGPT1, 2, and 4 and their corresponding RTK receptors Tie1 and 2 (tyrosine kinase with 
immunoglobulin and epidermal growth factor homology domains 1 and 2; Dumont et al., 1992; 
Sato et al., 1993) are involved with capillary maturation and stabilization, permeability, and 
inflammation (Fukuhara et al., 2008).  Specifically, ANGPT1 is expressed in pericytes that cover 
mature blood vessels (Suri et al., 1996) and ANGPT2 is expressed by endothelial cells and 
specialized tip cells (leading endothelial cells at the tips of vascular sprouts which coordinate 
multiple processes during angiogenesis; Siemerink et al., 2013) of sprouting blood vessels 
(Holash et al., 1999; del Toro et al., 2010).  Within endothelial cells, ANGPT2 is stored in 
secretory granules known as Weibel-Palade bodies.  Expression of ANGPT2 is increased in 
hypoxic conditions or during an inflammatory response (Fiedler et al., 2004).  Angiopoietins 
form unique multimeric structures, and a more complex multimer known as a tetramer, is 
required for Tie2 activation (Davis et al., 2003).  Because of the unique structure of ANGPT, Tie 
receptor complexes, unlike classic RTK receptors, are believed to be comprised of several 
receptor units that are activated by multimeric ligands (Davis et al., 2003).  When ANGPT1 
expression increases, Tie receptors are quickly translocated to cell-cell junctions wherein they 
arrange to make complexes that are capable of moving across the endothelial cell junctions 
(Fukuhara et al., 2008; Saharinen et al., 2008).  Once activated and in this subcellular location, 
the ANGPT1-Tie2 complex mediates endothelial cell survival, stabilization, and anti-
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inflammatory functions (Fukuhara et al., 2008; Sako et al., 2009).  In endothelial cells that are 
mobile, matrix-bound ANGPT1 activates Tie2 in cell matrices, which mediates changes in 
adhesion and cell mobility (Fukuhara et al., 2008).  As mentioned previously, ANGPT1 is also 
responsible for controlling vascular permeability and leakage caused by VEGF (Thurston et al., 
1999).    
Angiopoietin-specific Tie receptors are expressed in the blood and lymphatic 
endothelium and in some immunological cells, such as Tie2 positive macrophages (TEMs) 
(Mazzieri et al., 2011).  Blood flow and shear stress are considered common regulators of Tie1 
expression (Chen-Konak et al., 2003; Porat et al., 2004).  Mice offspring deficient in Tie1 
receptors die from embryonic day (E) 13.5 to birth; they have edema, hemorrhage, and poor 
endothelial cell structure (Puri et al., 1995; Sato et al., 1995).  Mice offspring lacking Tie2 
receptors die at an earlier stage (E10.5), with the most prominent defect being the lack of proper 
cardiac endothelial lining development and failure of remodeling in capillaries (Dumont et al., 
1994).  
 Chowdhury et al. (2010) reported that the ANGPT proteins are present in both granulosa 
and theca cells of the ovine ovarian follicle, but and that ANGPT mRNA was consistently 
expressed at greater concentrations in theca compared to granulosa cells.  In addition, ANGPT 
levels of expression are related to the stage of the estrous cycle and to follicle size (Chowdhury 
et al., 2010).  Vonnahme et al. (2006) observed no change in ANGPT1 mRNA expression in 
ovine CL after PGF2α-induced regression, while the expression of ANGPT2 decreased just 8 h 
post-PGF2α injection.  Oppositely, in the bovine CL, researchers have reported ANGPT1 mRNA 
decreased and there were no changes in the expression of ANGPT2 mRNA during luteal 
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regression.  Together, these data demonstrate that the expression pattern of ANGPT in luteal 
tissues is species specific (Vonnahme et al., 2006). 
Local administration of ANGPT to ovarian follicles have demonstrated that ANGPT are 
critical for both follicular development and ovulation.  Administration of anti-ANGPT1 antibody 
resulted in a delay in rat follicular development (Parborell et al., 2008).  Additionally, Xu et al. 
(2005) demonstrated that delivery of ANGPT2 to the preovulatory follicle not only prevents 
ovulation, but also terminates the menstrual cycle in rhesus monkeys.  Within the CL, ANGPT2 
is postulated to be involved in luteal tissue regression, as enhanced expression of ANGPT2 
mRNA occurs in late-luteal tissues when compared to mid-luteal tissues in humans (Sugino et 
al., 2005).   
Basic Fibroblast Growth Factors  
Fibroblast growth factors (FGF) were one of the first angiogenic proteins identified 
(Shing et al., 1984), now having at least 22 factors within the family.  Of these known proteins, 
they are 30 to 70% identical in their primary amino acid sequences (Cross et al., 2001) and are 
heparin-binding proteins.  FGF signaling regulates embryonic development, such as 
mesenchymal-epithelial signaling (De Moerlooze et al., 2000) and development of organ systems 
(Yamaguchi et al., 1994), and assists in cell proliferation, differentiation, and survival (Baird et 
al., 1986).  Endothelial cells have been reported to express the FGF-2 gene and synthesize 
bioactive FGF-2 protein (Schweigerer et al., 1987). 
The most studied FGFs, those being FGF-1 (acidic) and FGF-2 (basic), lack cytoplasmic 
sequences for extracellular secretion, which is in contrast to the majority of growth factors that 
are capable of being released from producer cells (Gospodarowicz et al., 1974).  This varying 
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system of FGF export has led to varying beliefs for its role in angiogenesis, such as extracellular 
sequestration and release suggested by Vlodavsky et al. (1991).  However, exact export 
mechanisms of FGF proteins are still not well understood (Lieu et al., 2011).  Multiple proteins 
to which FGFs bind have been identified.  First, FGFs bind with high affinity to heparan sulfate 
proteoglycans (HSPGs), which are located on cellular surfaces and within the extracellular 
matrix (Vlodavsky et al., 1991).  HSPGs modulate FGF effects under in vivo and in vitro 
conditions (Jaye et al., 1992).  Secondly, FGFs bind to four structurally related RTK receptors 
known as receptor (FGFR)-1, -2, -3, and -4, each with differing functions (Johnson and 
Williams, 1993).  Mice embryos lacking FGFR-1 or -2 expression died prior to gastrulation 
(Deng et al., 1997; Xu et al., 1998), and FGFR-1 is necessary for both the development and 
maintenance of embryonic blood vessels (Lee et al., 2000).  Disruption of FGFR-3 results in 
mice offspring with skeletal overgrowth and deafness (Colvin et al., 1996).  Lastly, FGFR-4 has 
been reported to be involved with metabolism and FGFR-4 KO mice have a glucose intolerance 
(Wu et al., 2009).         
While some FGFs are expressed during embryonic development exclusively, for 
example, FGF-3, 4, 8, 15, and 19, others such as FGF-1, 2, 5-7, 9-14, and 20-23 are expressed in 
both embryonic and adult tissues (review in Ornitz and Itoh, 2001). Within the ovary, FGF was 
one of the first angiogenic proteins found (Gospodarowicz et al., 1985) and has been identified in 
ovaries of livestock species (Stirling et al., 1991; Jablonka-Shariff et al., 1997; Reynolds et al., 
2000), and specifically the CL of sheep (Grazul-Bilska et al., 1993; Doraiswamy et al., 1998, 
Vonnahme et al., 2006).  The FGF-2 mRNA pattern of expression in bovine CL closely mimics 
that of angiogenic activity (Stirling et al., 1991) and FGF-2 mRNA is stimulated by LH, the 
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major luteotropic hormone in livestock (Redmer et al., 1987, 1988).  Moreover, in vitro 
incubation of luteal conditioned media with an FGF antibody immunoneutralized approximately 
80% of angiogenic activity in the cow, sow, and ewe (Reynolds et al., 2000).  A study utilizing 
endothelial cells derived from bovine CL demonstrated that FGF-1 was not expressed in 
endothelial cells, and that FGF-2 together with VEGF up-regulated both KDR and FLT receptors 
in vitro (Gabler et al., 2004). Schams et al. (1994) demonstrated that vascular cells express FGF-
2 in a phase-dependent manner in the bovine CL, while fibroblasts are known to increase in 
number in the regressing CL of several species including sheep (Farin et al. 1986, Sawyer et al. 
1990).  In fact, Vonnhamme et al. (2006) reported that FGF-2 mRNA expression first increased 
after induction of CL regression and then decreased.  
Regulation of Corpora Lutea Function 
Corpora Lutea Growth   
 Before ovulation, the antral follicle consists of a fluid, known as liquor folliculi, 
surrounded by an avascular layer of granulosa cells, a basement membrane and theca layer (as 
reviewed in Hazzard and Stouffer, 2000).  It is evident from many studies that the critical 
stimulus for luteinization is the luteinizing hormone (LH) surge that initiates ovulation 
(Kaltenbach et al., 1968; Murphy et al., 2004).  Moreover, the LH surge has long-term effects on 
the steroidogenic capability of luteal cells, including maintenance of cytochrome P450 enzyme 
(P450scc) and steroidogenic acute regulatory protein (StAR; Juengel et al., 1995; Murphy et al., 
2004), both necessary for P4 production.    
The CL forms after the oocyte is released from the antrum of the follicle at ovulation, and 
is the primary source of the gestational-support hormone progesterone (P4) (Diaz et al., 2002).  
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Luteal formation is essential for early embryonic development, implantation, and viviparity 
within most mammalian species (Murphy, 2004).  This structure is capable of phenomenal 
growth, rivaling even the fastest growing tumors (Reynolds et al., 2000), due to synergistic 
changes within vasculature.  In fact, during its growth phase, the CL doubles in size and cell 
number every 60 to 70 hours (Reynolds et al., 1994).  The capillaries expand by “sprouting”, or 
penetrating, into the previously avascular granulosa cell layer to form the dense capillary 
network in the developing luteal tissue, which, within the female reproductive tract, receive some 
of the highest blood flow rates per unit of tissue and exhibit a high rate of metabolism (Reynolds 
et al., 1986).  The CL is a unique endocrine gland due to its transient nature and is comprised of 
endothelial, small and large luteal, pericytes, smotth muscle cells, immune and fibroblastic cells 
(Lei et al., 1991).     
Corpora Lutea Differentiation  
 In livestock species, the granulosa and theca cells contribute to CL morphology 
(Reynolds et al., 2002), and rapid invasion of these cells, along with thecal-derived perivascular 
cells (Redmer et al., 2000; Redmer et al., 2001), allow for proper CL vascularization and 
development.  In ewes, small luteal cells are 12 to 20 µm in diameter, believed to be of follicular 
thecal cell origin, contain LH receptors, respond to both LH or cAMP with a 5 to 15 fold 
increase in P4 secretion, and often contain lipid droplets (Niswender et al., 2002).  Even within 
the mature CL, theca cells are found in close association with vascular elements and express 
genes associated with CL differentiation, such as the LH receptor, StAR, and low-density 
lipoprotein receptors (LDLr).  Large luteal cells are greater than 20 µm, are primarily of 
granulosa cell origin, secrete more P4 than small cells, and while containing LH receptors, are 
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not responsive to LH or cGMP with increased P4 production (Niswender et al., 2002).  There can 
be as much as a 10-fold increase in granulosa cell volume during luteinization (Smith et al., 
1994).  Among mammalian species, steroid production (P4) of luteal tissue is two or three times 
greater than steroid production (E2) of follicles (Murphy et al., 2004).  There are major increases 
within the functional CL in the expression of proteins that make up both high-density lipoprotein 
(HDL) and LDL cholesterol importation pathways during luteinization (Plotkin et al., 2002; 
Niswender et al., 2002), as cholesterol transportation to the inner mitrochondrial membrane is the 
rate-limiting step in P4 biosynthesis (Murphy et al., 2004).      
Corpora Lutea Regression 
Prostaglandin F2α is the primary luteolysin at the late luteal phase of the estrous cycle or 
at the end of pregnancy in several species (Carlson and Gole, 1978) and is produced by the 
uterus (as reviewed in McCracken et al., 1999; Diaz et al., 2002).  The CL, while refractory to 
the luteolytic action of PGF2α in the early luteal phase, becomes responsive to PGF2α once the 
CL is mature in several species (Marcinkiewicz et al. 1992; Boiti et al. 1998, 2001; Davis and 
Rueda, 2002).  Activation of luteolysis occurs by PGF2α binding to its receptor within the large 
luteal cells (Niswender et al., 2002), which activates phospholipase C, causing the release of 
intracellular Ca2+ from the endoplasmic reticulum and activating of PKC isoforms (McGuire et 
al., 1994; Davis and Rueda, 2002).  This signaling pathway results in further increase of PGF2α 
release from the uterus, and also stimulates the release of oxytocin from the pituitary gland in 
ruminants (Davis and Rueda, 2002; Sirois et al., 2004).  The feedback loops formed between 
PGF2α and oxytocin serve as luteolytic signals, with the CL acting as an amplifier (Sirois et al., 
2004).  Structural luteolysis also results in physical destruction and regression from the ovary 
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(Davis and Rueda et al., 2002; Bowen-Shauver and Gibori, 2004).  This action is stimulated by 
an acute increase in luteal blood flow as the possible trigger of the luteolytic cascade (Acosta et 
al., 2002).  PGF2α is released by the uterus and stimulates both NO production and release in 
peripheral arteriolar vasculature of the mature CL (Friden et al., 2000; Miyamoto et al., 2005).  
An increase in NO production leads to an increase in blood flow to the CL.  This also increases 
shear stress and PGF2α, the latter increasing angiotensin II secretion from microvilli within the 
CL (Miyamoto et al., 2005).  These changes are partially responsible for later vasoconstriction 
and regression in the CL.  
It should be noted that while PGF2α is no longer contested as a mammalian luteolysin 
(Sirois et al., 2004), it remains unclear if it is directly responsible for luteal cell death.  In the 
ewe, luteal cells that produce PGF2α receptor (FP) are not the first to die during PGF2α-induced 
luteolysis (Davis and Rueda, 2002).  In fact, subluteolytic administration of PGF2α in ewes can 
reduce P4 secretion without resulting in a major loss of luteal cells, leading researchers to 
postulate that the prostaglandin has an indirect effect on luteolysis in certain species (McCracken 
et al., 1999; Davis et al., 2002). 
Arginine 
Arginine Effects on Vascular Function 
Arginine (Arg) is an amino acid (aa) that was first discovered in seedlings (Schultz and 
Steiger, 1886) and later in animal proteins (Hedin, 1895).  Research commenced in the late 
1940’s led to the classification of Arg as a semi-essential aa, as dietary Arg was required for 
growth of the chick (Klose et al., 1938) and rat pup (Wolf and Corley, 1939), but not for healthy 
adult rats (Borman et al., 1946).  Around the same time, researchers also reported that Arg was 
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required for creatine synthesis (Foster et al., 1939).  Arg is a precursor for multiple cell 
regulators including cell signaling molecules glutamate, agmatine, and NO (Palmer et al., 1998) 
(Figure 1.2).  Polyamines, which are necessary for ion channel function (Williams, 1997), are 
also derivatives of Arg.   
While Arg can be acquired exogenously through the diet, 40% of dietary Arg is 
catabolized by the small intestine before it can enter the blood stream (Wu and Morris, 1998).  
The majority of endogenously acquired Arg is derived from the intestinal-renal pathway.  Within 
the small intestine, the enterocyte is responsible for citrulline or arginine synthesis from 
glutamine and glutamate (Wu and Knabe, 1995).  These precursors are catabolized by the small 
intestine (Windmueller and Spaeth, 1975), both being major precursors for endogenously 
synthesized Arg (Wu, 1998).  The small intestine produces and releases citrulline into the blood 
circulation wherein it is extracted by the kidneys and stoichiometrically converted to Arg by 
enzymes arginosuccinate synthase (ASS) and arginosuccinate lyase (ASL) (Dhanakoti et al., 
1990).  The kidneys synthesize approximately 60% of net Arg in adult mammals (Dhanakoti et 
al., 1990; Yu et al., 1996).  With only 5-15% of endogenous synthesis being de novo, the major 
contributor to Arg flux is whole-body protein turnover, or “protein recycling” (taken from Wu 
and Morris, 1998).  However, evidence supports the theory that Arg synthesized within the urea 
cycle is not available for hepatic NO synthesis (Pastor et al., 1995) and that Arg from 
extracellular fluid is the preferred substrate for NO production by endothelial cells (Forstermann 
et al., 1994; Kurz and Harrison, 1997; Wu et al., 1998).     
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In Vivo Arginine Supplementation 
 Arginine supplementation has improved NO-dependent endothelial-stimulated relaxation 
(Figure 1.2) in patients with high cardiovascular risk factors and common cardiovascular 
disorders (such as coronary artery disease and heart failure) (Wu and Meininger et al., 2000; 
Maxwell and Cooke, 2001).  Researchers have reported that feeding an Arg- or protein-deficient 
diet to young rats not only decreases plasma Arg concentrations and also prevents maximal 
synthesis of NO (Wu et al., 1999).  Others have observed that supplementation of rumen-
protected Arg to non-pregnant ewes has resulted in increased blood flow to ovaries (Saevre et al., 
2011).  Recently, however, Kaminski et al. (2015) reported no changes in serum metabolites or 
hormones in non-pregnant ewes of various nutritional planes treated with Arg.  
 Supplementation of Arg to pregnant animals (through diet or injected intravenously) has 
also been investigated, with the goal being to potentially increase NO and, therefore, vasodilation 
of blood vessels.  Sows supplemented with Arg had a 22% increase in the number of live piglets 
born (Mateo et al., 2007) and by 30% in rats (Zeng et al., 2008).  Ewes provided additional Arg 
during late gestation had increased offspring number (Luther et al., 2009) and lamb birth weights 
(De Boo et al., 2005) compared to control offspring.  Moreover, ewe lambs were 12% heavier at 
birth when dams were supplemented with Arg i.v. when compared to ewe lambs from untreated 
dams (McCoard et al., 2013).   
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Figure 1.2. Arginine metabolism. Arginine can be derived from exogenous sources (dietary 
components) or endogenous sources (intestinal-renal pathway) and can be converted to several 
metabolites including creatine, citrulline, agmatine, and nitric oxide.  Arginine can also be 
utilized within the urea cycle.  Conversion of Arg is catalyzed by several enzymes and/or 
metabolic factors including arginine decarboxylase (ADC), arginase 1 (ARG1), glycine 
amidinotransferase (GATM), and nitric oxide synthase (NOS). NO, nitric oxide. 
 
When undernourished ewes were provided Arg supplementation, fetal growth restriction 
was prevented and lamb birth weight was enhanced by 21% (Lassala et al., 2010).  However, to 
our knowledge, the effects of Arg supplementation to non-pregnant animals of different 
nutritional planes on reproductive processes have not been investigated in detail. 
In Vitro Arginine Supplementation 
Mouse follicle culture absent of Arg resulted in significantly reduced follicle survival and 
ovulation, with nearly half the follicles surviving when compared to control cultures containing 
Arg (Mitchell et al., 2004).  Researchers have also observed varying morphological development 
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when comparing follicles grown with or without Arg, with those grown in the absence of Arg 
generally having dark granulosa cells, degenerating cells, and/or prematurely releasing a nude 
oocyte (Mitchell et al., 2004).   
However, the addition of Arg to Arg-free medium has resulted in a significantly greater 
follicle survival rate when compared even to a control, complete medium (Mitchell et al., 2004).  
Researchers have reported that in vitro Arg supplementation to d 16 ovine conceptuses resulted 
in a 12-fold increase in proliferation of trophectoderm cells (Kim et al., 2011).   
Conversely, elevated Arg inhuman FF has been associated with reduced oocyte retrieval 
and in vitro fertilization rates (Bodis et al., 2010).  Furthermore, researchers have observed 
attenuated LH-stimualted P4 secretion from granulosa cells obtained from nutritionally 
compromised ewes (Grazul-Bilska et al., 2015).  Together, these studies suggest that there may 
be an optimal dose of Arg necessary for normal luteal cell function.   
Nitric Oxide 
Nitric Oxide Production and Function 
Nitric oxide is a mediator of many physiological mammalian processes, including 
reproductive functions (Ignarro et al., 1990; Biswas et al., 1998).  Nitric oxide, also known as 
endothelial-derived relaxing factor (EDRF), was first named by Dr. Robert Furchgott (Furchgott 
and Zawadski, 1980).  Dr. Furchgott, along with other researchers, discovered this free radical 
gas and some of its various actions; the most researched focusing on vascular smooth muscle cell 
(VSMC) relaxation.  NO is a small biological product of mammalian cells (Nathan, 1992) and 
has a half-life of less than 5 seconds (Palmer et al., 1987). 
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There are three isoform enzymes responsible for NO production from Arg.  The brain, 
vascular endothelium, and macrophages were the first areas where these enzymes were 
discovered to play a specific function, hence the nomenclature (Forstermann et al., 1991; Stuehr 
and Griffith, 1992).  While termed neuronal constitutive NO synthase (NOS I or nNOS), 
endothelial constitutive NO synthase (NOS III or eNOS), and inducible NO synthase (NOS II or 
iNOS), these isoforms are distributed across a wide spectrum of cell types (Stuehr and Griffith, 
1992).  Production of NO induced by iNOS occurs with a delay of approximately six to eight 
hours after stimulation, yet once induced, iNOS is active for hours or even days and produces 
NO in 1000-fold larger quantities than the constitutive forms (Huang et al., 1993; Nathan Xie, 
1994; Beck et al., 1999; Moncada et al., 2002).  Together, nNOS and eNOS are responsible for 
the continuous basal release of NO and both enzymes require the calcium-calmodulin complex 
for activation (Griffith and Stuehr, 1995; Snyder, 1995).  Researchers have also reported that a 
cell type can express more than one NOS isoform (Radomski et al., 1990; Suschek et al., 1993).   
Increased intracellular calcium (Ca2+) concentrations initiate a cascade of events leading 
to eNOS or nNOS activation.  Intracellular Ca2+ both binds calmodulin (CaM) to form calcium-
calmodulin complexes and regulates the binding of CaM to target proteins.  Therefore, by 
binding to CaM, Ca2+ causes significant conformational changes with the hydrophobic face of 
the target recognition site (O’Neil and DeGrado, 1990). This allows electron transport from 
NADPH within the reductase group to the heme-containing active site, facilitating the 
conversion of O2 and Arg to NO and citrulline (Abu-Soud et al., 1994).  It should be noted that 
maximal NOS activity is dependent upon substrate availability and co-factors NADPH, flavin 
mononucleotide (FMN), flavin adenine dinucleotide (FAD), and tetrahydrobiopterin (THB), and 
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the availability of these factors determines the cellular rates of NO synthesis (Morris and Billiar, 
1994; Davies et al., 1995).  These dependencies for NO production implies that metabolic 
activity pathways either generate or compete for these cofactors (whether during normal 
physiological or pathological conditions) can be important to determining cellular NO 
production rates.  Additionally, NO can regulate its own activity.  Assreuy et al. (1993) 
demonstrated that NO synthesis is not linear after 20 minutes, suggesting the possibility of a 
negative feed-back inhibition.  Once NO is produced, it can carry out multiple functions in two 
different ways: 1) by binding and activating soluble guanylyl cyclase (sGC), or 2) through s-
nitrosylation (Assreuy et al., 1993). 
The short half-life of NO dictates its mediation of many biological functions.  NO 
produced by endothelial cells, diffuses into the blood and binds to the heme group within 
hemoglobin in the red blood cells, or diffuses to pericytes and SMC (Foster et al., 2009).  
However, as Foster et al. (2009) explains “…hemes do not generally elicit cellular signaling 
involving posttranslational modifications of proteins and thus an explanation for most NO-based 
bioactivity was not apparent.”  Within smooth muscle cells, NO binds to the heme group of sGC 
(Stone and Marletta, 1994) (Figure 1.2), which seems to be the most relevant target of NO at low 
concentrations (Maul et al., 2003).  This binding catalyzes dephosphorylation (cleavage of two 
phosphate groups) of guanosine triphosphate (GTP) to 3΄, 5΄-cyclic guanosine monophosphate 
(cGMP), which serves as a second messenger for many important cellular functions and also 
activates protein kinase G (PKG) (Denninger and Marletta, 1999).  Cyclic GMP then induces 
VSMC relaxation by inhibiting cellular Ca2+ entry.  Cellular Ca2+ entry inhibition by activated 
cGMP activates K+ channels, which leads to VSMC hyperpolarization (Denninger and Marletta, 
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1999).  This activity stimulates a cGMP-dependent kinase, myosin light-chain kinase (MLCK), 
which dephosphorylates myosin light-chains, as the name implies, and causes muscle cell 
relaxation and, therefore, dilation of the NO-exposed blood vessel (Denninger and Marletta, 
1999) (Figure 1.3).  Blood vessel dilation allows for increased amounts of O2 and nutrients that 
can be delivered to appropriate tissues.  Increased concentrations of cAMP also activates, in turn, 
three vital signaling pathways, including 1) cGMP-regulated ion channels, 2) cGMP-regulated 
protein kinases, and 3) cGMP-dependent protein kinases and phosphatases (as reviewed in Beck 
et al., 1999).  Furthermore, NO and its downstream signaling cascades also are responsible for 
platelet aggregation prevention (Ignarro et al., 1999), increasing endothelial cell proliferation 
(Morbidelli et al., 1996; Ziche et al., 1997) and migration (Ziche et al., 1994), and act as a 
neurotransmitter and mediator of the immune system (Bredt et al., 1999) in mammals.  Since 
there is only a limited amount of guanylyl cyclase (GC) enzyme present in one SMC, and once 
all GC enzyme have been activated, additional NO cannot initiate any further dilation.  Instead, 
unused NO will be appropriated as a nitrosothiol bound to hemoglobin in red blood cells (RBCs) 
for future usage (Burke, 2002).  
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Figure 1.3. Mechanism of blood vessel relaxation induced by NO.  L-Arginine (L-Arg) is 
converted to nitric oxide (NO) via enzyme nitric oxide synthase (NOS) within the endothelial 
cells.  Nitric oxide then diffuses into the smooth muscle cells where it can bind guanylate cyclase 
(GC), causing an increase in cyclic guanosine monophosphate (cGMP), which then causes an 
increase in Protein Kinase G (PKG).  The increase in PGK reduced intracellular calcium (Ca++) 
concentrations, allowing for smooth muscle cell relaxation and dilation of the blood vessel.   
 
A second way in which NO can carry out various actions in cell signaling transduction is 
through s-nitrosylation, through the formation of S-nitroso-proteins, what are collectively termed 
SNO-proteins.  S-nitrosylation is the result of the attachment of NO to a thiol sidechain of, 
generally, a cysteine (Cyst) residue (Foster et al., 2003; Hess et al., 2005; Sen and Snyder, 2010).  
Nitric oxide can actually interact with and modify many different cellular molecules including 
other free radicals, redox regulators (such as glutathionine), and macromolecules (such as DNA 
and other proteins) and there are over 3,000 SNO-proteins currently known (Benhar et al., 2009).  
There are many types of post-translational modifications, such as palmitoylation, 
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phosphorylation, ubiquitation, sumolation, acetylation, and others (Stamler and Meissner, 2001).  
S-nitrosylation is similar to these in modifications in multiple ways (Stamler and Meissner, 
2001); for example, both S-nitrosylation and many of these processes lead to covalent 
modifications of proteins.  However, the post-translational modifications listed above are driven 
by enzymes, whereas S-nitrosylation is reliant strictly upon the chemical reactivity between the 
NO molecule and its target.  SNO-proteins are often within close proximity to eNOS or nNOS, 
providing a type of compartmentalization within cells (Lima et al., 2010).  While protein S-
nitrosylation is vital for many cellular changes, hypo- or hyper-S-nitrosylation of target proteins, 
and, therefore, alterations in protein function can contribute to many human ailments such as 
cardiovascular, musculoskeletal, and nervous system disorders (Foster et al., 2009; Gu et al., 
2010).  
Nitric Oxide and NOS Localization and Expression in Follicles and Corpora Lutea 
   Detection of both eNOS and/or iNOS in stroma, granulosa, and theca cells of rat, mouse 
and/or ovine ovarian follicles have been reported (Van Voorhis et al., 1995; Zackrisson et al., 
1996; Jablonka-Shariff and Olson, 1997; Grazul-Bilska et al., 2006).  Moreover, researchers 
have reported that eNOS mRNA was expressed in the blood vessels of developing and pre-
ovulatory follicles (Grazul-Bilska et al. (2006).  A distinct cell-specific eNOS and iNOS 
expression pattern depends on the stage of the estrous cycle (Zackrisson et al., 1996; Jablonka-
Shariff and Olson, 1997; Grazul-Bilska et al., 2006).  In sows, eNOS immunoreactivity increased 
in parallel with follicular size; there were lesser eNOS expression concentrations in smaller 
follicles and greater expression in larger follicles (Tao et al., 2004).  In contrast, no 
immunoreactivity for iNOS was found in primordial, early antral follicle or the cumulus oocyte 
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complexes (COC) aspirated from small and medium follicles in porcine ovaries; however, the 
large follicle-enclosed oocyte had weak immunoreactivity to iNOS (Tao et al., 2004).  While 
most tissues only express iNOS in response to immune stimuli (such as trauma or infection), 
iNOS expression in mature ovaries has been observed (Zackrisson et al., 1996).  Nitric oxide 
synthase has also been localized in luteal tissues; Vega et al. (1998) detected the expression of 
eNOS in mid- and early, and to a lesser extent, in late CL.  Additionally, an 
immunohistochemical study in women indicated that both eNOS and iNOS were expressed in 
mid-luteal CL, eNOS being the more abundant enzyme present.  Through immunoreactivity, all 
NOS isoforms have been observed in luteal cells from early-, mid-, and late-luteal phase bovine 
CL (Zerani et al., 2013).   
Nitric Oxide Functions in Female Reproduction 
It should also be noted that one of the major contributors to eNOS expression, and 
therefore NO production, is VEGF (Ku et al., 1993; Van der Zee et al., 1997; Kroll and 
Waltenberger, 1998; Duda et al., 2004).  Nitric oxide, in turn, assists in VEGF expression 
regulation and angiogenesis (Chin et al., 1997; Reynolds et al., 2000, 2002; Beckman et al., 
2006).  An existence of a paracrine loop was postulated, wherein endothelial cells secrete NO, 
stimulating perivascular VEGF production, which then stimulated endothelial expression of 
eNOS.  Within the ovarian structure, this paracrine loop would provide a “feed-forward” system 
to increase vasodilation and angiogenesis, which are vital to proper ovarian function (Reynolds 
et al., 2002).   
Researchers have postulated that E2 is one of the major reproductive hormones regulating 
NO production in the vasculature and reproductive tract, indicating that E2 stimulates vascular 
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NO by upregulating eNOS and/or inhibiting superoxide anion production in ewes (Van Buren et 
al., 1992) and guinea pigs (Weiner et al., 1994). 
Because NO inhibits apoptotic DNA fragmentation in granulosa cells, researchers 
postulate that NO is an important modulator and vital for follicular development and survival 
factor (Tilly and Tilly, 1995).  Supporting this is the observation that NO concentration within 
FF increases with follicular development and are correlated with increased E2 concentrations 
(Rosselli et al., 1994, 1998).   
Studies utilizing NO donors and inhibitors have demonstrated the growth-promoting 
effects of NO to ovarian follicle granulosa cells since 1) NO donors increase epidermal growth 
factor receptors on granulosa cells, while 2) NO synthesis inhibitors decrease these same 
receptors (Hattori et al., 1996).  To investigate the role of NO in the ovulatory process, 
researchers utilized NOS inhibitors Ng-methyl-L-arginine and aminoguanidine, which resulted in 
a dose-dependent reduction of hCG-induced ovulation in rats (Shukovski and Tsafriri, 1994).  
The administration of a NO donor reversed the anti-ovulatory effect, suggesting NOS is involved 
in ovulation.  Because NOS inhibition reduced ovulation by approximately 54% in rats, it has 
been postulated that NO is also involved in the ovulation process.  
Nitric oxide regulates oocyte meiotic maturation in rodents (Jablonka-Shariff et al., 1999) 
and in vitro (Kazuo et al., 2001).  Bu et al. (2003) reported data supporting the theory that NO 
could have dual actions pertaining to meiotic maturation, acting in some instances as a stimulator 
and in other cases as an inhibitor, depending on NO concentration, and hypothesized that the 
action of NO on oocyte maturation acts through the cGMP pathway.  An oocyte within a 
Graafian follicle is arrested in the first meiotic division; high concentrations of cAMP and cGMP 
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in the oocyte are necessary for this arrest phase, and NO is a known cGMP stimulator (Eppig et 
al., 1991, 2004).  An LH surge leads to a systematic decrease in NO concentrations and, 
therefore, a decrease in cAMP and cGMP, allowing for meiotic resumption (Eppig et al., 2004).  
When Bu et al. (2003) supplemented medium with sodium nitrioprusside (SNO; a NO donor) 
polar body extrusion was inhibited.  Oppositely, low concentrations of SNP had stimulatory 
effects on oocytes.  This paradox led researchers to postulate that NO can have opposing effects, 
dependent upon NO concentration, on oocyte maturation.  Moreover, the evaluation of 
nitrite/nitrate concentrations in culture medium revealed that a low concentration of NO (30.69 ± 
5.06 µmol) stimulated meiotic maturation of mouse oocytes, while a high concentration (59.88 ± 
8.07 µmol) inhibited it.  Similar results have been demonstrated in livestock species.  The 
administration of NOS inhibitors during in vitro oocyte pre-maturation and/or at maturation 
affect embryo development and quality, causing a decrease in bovine (Bilodeau-Goeseels, 2007; 
Schwarz et al., 2010), porcine (Tao et al., 2004) and caprine (Amale et al., 2013). 
Furthermore, Dong et al. (1999) have demonstrated that NO donor diethylenetriamine 
(DETA-NONOate) increased in a dose-dependent manner P4 secretion by rat ovaries.  
Moreover, NO was capable of reversing the PGF2α -induced inhibition of rat ovarian P4 
secretion in vitro (Dong et al., 1999), which is contradictory to the findings of other researchers 
utilizing rat CL (Motta et al., 1999).  The latter researchers suggested the involvement of NO in 
CL regression, reporting that increased NO production increases PGF2α concentrations during 
the last two days of luteal development, demonstrating a positive feedback mechanism between 
the two to ensure CL regression (Motta et al., 1999).    
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While PGF2α is considered to be the main luteolytic hormone, several studies examining 
the direct effects of PGF2α on bovine populations of steroidogenic luteal cells demonstrate that 
the addition of PGF2α alone does not inhibit basal P4 production from large luteal cells (Alila et 
al., 1988; Meidan et al., 1992; Girsh et al., 1995; Okuda et al., 1998) and actually stimulates P4 
secretion from small luteal cells (Okuda et al., 1998; Skarzynski and Okuda, 2000).  Due to these 
results, researchers have suggested that some other biomolecule produced within the CL may be 
responsible for mediating PGF2α and CL regression (Meidan et al., 1998; Korzekwa et al., 2006).  
Therefore, it has been postulated that NO acted as a mediator for PGF2α in bovine luteal tissue 
(Jaroszewski et al., 2000), as in vitro NO donors inhibit P4 secretion from bovine luteal cells 
(Skarzynski and Okuda, 2000; Jaroszewski et al., 2003) and enhances luteolytic activity 
(Jaroszewski et al., 2000).  Supporting the suggestion that NO mediates luteolytic activity are the 
cumulating results that demonstrate 1) decreased NO concentration via NO inhibitors to luteal 
cell cultures result in increased P4 concentrations in women (Van Voorhis et al., 1994), rabbits 
(Gobbetti et al., 1999), and cows (Skarzynski and Okuda, 2000; Jaroszewski et al., 2003), and 2) 
increased NO concentration within luteal cell culture by administration of NO donors in rats 
(Motta and Gimeno, 1997), rabbits (Gobbetti et al., 1999) and cows (Jaroszewski et al., 2003).  
An inverse relationship between treatment of spermine NO complex (an NO donor) to luteal cell 
cultures and luteal cell viability has been observed in bovine (Jaroszewski et al., 2003).  
Consequently, P4 inhibition after spermine-NO complex administration may be due to luteal cell 
viability reduction.  Conflicting results regarding NO inhibitors have also been demonstrated; 
Olson et al. (1996) reported the supplementation of NO synthase inhibitor Nω –nitro-L-arginine 
methyl ester reduced endogenous NO production, but did not affect P4 production from 
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luteinized rat ovaries.  Differing results reported could be due to different NO donor or 
inhibitors, culture conditions (e.g., length of culture, different media, different cell concentration 
and others), and/or species.      
Nitric Oxide Synthase Knockout Animals and Reproduction 
Female eNOS KO mice lack eNOS within tissues, including lack of immunoreactivity 
within the ovary (Drazen et al., 1999).  Mice treated with L-NAME, (L-NG-nitroarginine methyl 
ester) a NOS inhibitor, are characterized by shorter estrous cycles (Drazen et al., 1999), impaired 
follicular and oocyte growth, a decreased follicular cohort, abnormal meiotic maturation, reduced 
ovulation rates, and increased oocyte death rates when compared to wild type (WT) control mice 
(Jablonka-Shariff et al., 1999; Drazen et al., 1999; Pallares et al., 2008).  Specifically, Jablonka-
Shariff (1999) utilized eNOS deficient mice to demonstrate altered steroidogenesis, abnormal 
estrous cycles, and reduced ovulation in rats.  These results, along with other studies 
demonstrating altered ovarian blood flow after NO inhibition (Jablonka-Shariff et al., 1999), 
suggest that role of eNOS in the ovulatory process is to enhance ovarian blood flow to the 
developing follicle (Kassab et al., 1998).  Pregnant eNOS KO mice also have narrowed uterine 
arteries when compared to WT mice (Kulandavelu et al., 2012), demonstrating the importance of 
NO to arterial structural changes.  The absence of functional iNOS through KO has no effect on 
ovulation in rodents (Hefler and Gregg, 2002).  Instead, while expression of iNOS in the rodent 
ovary is profuse (Hefler and Gregg, 2002), NO derived from iNOS stimulated by interleukin-1β 
was reported to be a vital mediator of cell death and to stimulate tissue remodeling events during 
in vivo ovulation (Ellman et al., 1993).  Together, these data demonstrate that NO is involved in 
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the maintenance of ovarian vascular function, as well as the regulation of follicle and luteal 
tissue angiogenesis (Grazul-Bilska et al., 2006).    
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CHAPTER 2: LUTEAL FUNCTION DURING THE ESTROUS CYCLE IN ARGININE-
TREATED EWES FED DIFFERENT PLANES OF NUTRITION: CELL 
PROLIFERATION, VASCULARIZATION, AND EXPRESSION OF ANGIOGENIC 
FACTORS 
Abstract 
 
Numerous factors influence corpus luteum (CL; luteal tissue) function and includes 
hormones, growth and angiogenic factors, nutritional plane, and supplements such as arginine 
(Arg), a semi-essential amino acid and precursor for proteins, polyamines, and nitric oxide (NO).  
During the estrous cycle, the CL undergoes rapid changes including vascular development and 
regression, and tissue growth and regression.  The aim of this study was to determine if Arg 
supplementation to nutritionally compromised ewes impacts 1) progesterone (P4) concentrations 
in serum and luteal tissue, 2) luteal vascularity, cell proliferation, endothelial nitric oxide 
synthase (eNOS), and receptor soluble guanylate cyclase (sGCβ) protein and mRNA expression, 
and 3) luteal mRNA expression for selected angiogenic factors during the estrous cycle.  Ewes 
were categorized by weight and randomly assigned to one of three different nutritional planes: C 
(2.14 Mcal/kg; n=37), O (2xC; n=37), and U (60% of C; n=37) beginning 60 days prior to Arg-
treatment.  After estrus synchronization, ewes from each diet were assigned randomly to one of 
two treatments; Arg (L-Arg-HCl; 155 µmol Arg/kg BW) or saline (~10 ml).  Serum and CL were 
collected at the early, mid and late luteal phases.  The present study demonstrates that 1) 
nutritional plane affects ovulation rates, serum P4 concentrations, and KDR mRNA expression, 
2) Arg affects luteal vascularity and the NO system and 3) luteal vascularity, cell proliferation, 
and the VEGF systemdepends on the stage of the estrous cycle, and 3).  These data indicate that 
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plane of nutrition and Arg supplementation can alter vascularization and expression of related 
angiogenic factors in luteal tissue during the estrous cycle.  In addition, our data further support 
previous observations that the VEGF and NO systems are involved in the regulation of luteal 
function throughout the estrous cycle in sheep.   
Introduction 
 
The CL forms after ovulation and is the primary source of the gestational-support 
hormone P4 (Corner and Allen, 1929; Diaz et al., 2002).  During its growth phase, the CL 
doubles in size and cell number every 60-70 hours and is capable of tremendous growth due to 
coordinated changes within vasculature (Reynolds et al., 1994).  The CL receive some of the 
highest blood flow rates per unit of tissue, exhibit a high rate of metabolism, and contain 
parenchymal (e.g., steroidogenic) and non-parenchymal cells (e,g., fibroblasts, immune cells and 
vascular cells such as pericytes, smooth muscle cells and endothelial cell) (Reynolds et al., 2000; 
Redmer et al., 2001; Grazul-Bilska et al., 2001).  Vascular cells comprise 40-70% of the total 
cell population within the mature CL, and the majority of steroidogenic cells within the CL are in 
direct contact with one or more capillaries (Reynolds et al., 1992, 2000).  
Nutritional plane, including either undernutrition or overnutrition, impacts several female 
reproductive functions including follicular growth (Diskin et al., 2003; Webb et al., 2004, 2007), 
oocyte quality (Rhind et al., 1989: Grazul-Bilska et al., 2012), ovulation (O’Callaghan and 
Boland, 1999), luteal function and hormone production (Abecia et al., 1997; Parr et al., 1987; 
Armstrong et al., 2003; Diskin et al., 2003; Kaminski et al., 2015).  Additional studies regarding 
inadequate diet effects on ovarian function in ewes is important as the nutrient uptake of grazing 
ewes in the western United States is often less than 50% of the National Research Council’s 
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(NRC) recommendation (NRC, 1985) (Thomas and Kott, 1995).  Moreover, the ewe is a 
seasonal breeder, becoming pregnant in late fall or early winter in the US; this results in the 
majority of gestation coinciding with winter, when grazing forages are of lower quality 
(Hoaglund et al., 1992).   
Arginine is a semi-essential amino acid obtained through exogenous (via diet; Mertz et 
al., 1952; Wu and Morris, 1998) and endogenous (via intestinal-renal pathway; Windmueller and 
Spaeth, 1981; Wakabayashi and Jones, 1983; Wu and Knabe, 1995) sources.  While Arg is a 
precursor for proteins and polyamines, it is also a physiological nitrogen donor for nitric oxide 
synthase (NOS) that catalyzes NO formation.  In addition, whether through competitive 
inhibition of Arg (Morris and Billiar, 1994; Carter et al., 2004) or through a low-Arg diet (Wu et 
al., 1999; Wu and Meininger, 2002), reduced systemic Arg concentration impairs NO 
production.  Moreover, several studies have demonstrated that NO production catalyzed by 
eNOS is primarily determined by extracellular Arg bioavailability (Hallemeesch et al., 2002; 
Hardy et al., 2002; Rajapakse et al., 2009; Shin et al., 2011).    
It has been clearly demonstrated that NO is one of the major regulators of vascular 
development and angiogenesis within the ovary (Reynolds et al., 2002), and has been implicated 
in the regulation of luteal function (Motta et al., 1999, 2001).  For several species including cows 
and sheep, effectors of the NO system have direct effects on steroidogenesis in luteal tissues 
(Vega et al., 1998; Mitsube et al., 1999; Dong et al., 1999; Skarzynski et al., 2000; Jaroszewski 
et al., 2001, 2003; Hurwitz et al., 2002).  Three NOS isoforms, endothelial (eNOS), neuronal 
(nNOS), and/or inducible (iNOS) have been detected in the luteal cells during early-, mid-, and 
late-luteal phases in several species (Skarzynski et al., 2003; Rosiansky-Sultan et al., 2006; 
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Grazul-Bilska et al., 2006; Zerani et al., 2013).  Hurwitz et al. (2002) reported that iNOS-
mediated NO production is involved in regulation of prostaglandin synthesis in rat luteal cells, 
which may alter P4 synthesis.   
One of the major regulators of eNOS expression, and therefore NO production, is 
vascular endothelial growth factor (VEGF) (Ku et al., 1993; Van der Zee et al., 1997; Kroll and 
Waltenberger, 1999; Duda et al., 2004).  Nitric oxide, in turn, is involved in regulation of VEGF 
expression and thus angiogenesis (Chin et al., 1997; Reynolds et al., 2000, 2002; Beckman et al., 
2006).  The existence of a paracrine loop, wherein endothelial cells secrete NO, stimulating 
perivascular VEGF production, which then stimulate endothelial expression of eNOS has been 
proposed for reproductive tissues (Reynolds et al., 2002).  Within the ovarian structure, this 
paracrine loop would provide a “feed-forward” system to increase vasodilation and angiogenesis, 
which are vital to proper ovarian function (Reynolds et al., 2002).   
The CL growth and regression, as well as vascularization, is regulated by numerous 
factors including members of the VEGF, angiopoietins (ANGPT), and fibroblast growth factor 
(FGF) families and the NO system (Friden et al., 2000; Boiti et al., 2002; Miyamoto et al., 2005; 
Vonnahme et al., 2006; Beckman et al., 2006).  The VEGF family of proteins including VEGF, 
placental growth factor (PGF) and receptors FLT and KDR is considered to be one of the major 
regulators of angiogenesis and vascular function (Ferrara, 1999; Geva and Jaffe et al., 2000; 
Hoeben et al., 2004).  Another importan regulators of angiogenesis, angiopoietins (ANGPT)-1 
and -2 are produced exclusively by endothelial cells, are responsible for blood vessel maturation 
or destabilization, respectively, and bind receptor Tie (tyrosine kinase with immunoglobulin and 
epidermal growth factor homology domains) 1 and 2 (Dumont et al., 1992; Sato et al., 1993).  
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Basic fibroblast growth factor (FGF2) is one of many fibroblast growth factors and is involved in 
regulation of angiogenesis and tissue growth (Baird et al., 1985; Kottakis et al., 2011).  FGF2 
binds its receptor FGFR2 (Johnson and Williams, 1993).   
Objectives and Hypotheses 
 We hypothesized that inadequate nutrition (either diet excess or restriction) would result 
in negative effects on CL function, while Arg would restore function as evaluated by serum and 
luteal P4 concentrations, vascularization, cell proliferation, expression of eNOS and NO receptor 
sGC proteins, and mRNA expression of selected angiogenic factors in CL.  Therefore, the aim of 
this study was to evaluate the effects of nutritional plane and Arg on 1) CL number and weight, 
2) serum P4 concentration and P4 content in CL, 3) CL vascularization and cell proliferation as 
measured by protein expression of CD31 and Ki67, respectively, 4) luteal eNOS and sGC-beta 
protein expression, and 5) luteal mRNA expression of eNOS, GUCY1B3, VEGF, PGF, FLT, 
KDR, ANGPT1, ANGPT2, TIE2, FGF2 and FGF2R during the estrous cycle.  
Materials and Methods 
All animal procedures performed were approved by the North Dakota State University 
Institutional Animal Care and Use Committee (#A12013). 
Animals and Experimental Design  
Animal treatments, diet composition and experimental design are described in detail by 
Kaminski et al. (2015).  Briefly, non-pregnant, non-lactating Rambouillet ewes (n = 111, 
between 3 to 5 years of age and of similar genetic background) were penned individually at the 
Animal Nutrition and Physiology Center on the NDSU campus.  Ewes were stratified by weight 
and randomly assigned to one of three nutritional plane treatments: control (C; n = 37) received a 
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maintenance diet (760 g/kg BW/day), overfed (O; n = 37) received 2 x C, and underfed (U; n = 
37) received 0.6 x C 60 days prior to the onset of the estrous cycle (day 0).  Ewes were fed their 
individual diets twice daily at 0800 h and 1500 h.  Ewes were weighed and BCS was evaluated 
on a 5-point scale (1 = extremely thin and 5 = obese) by the same individual once weekly.  Diets 
were adjusted weekly to ensure the proper BW.  Body condition score was achieved by day 0 
and maintained throughout the estrous cycle until completion of experiment on day 15 (late-
luteal phase of the first estrous cycle), or day 21 or day 26 (early-luteal phase or mid-luteal phase 
of the second estrous cycle, respectively) of Arg.  Estrus was synchronized by insertion of a 
controlled internal drug release device for 14 days.  Based on previous results (Grazul-Bilska et 
al., unpublished), approximately 36 h after CIDR removal, ewes were in estrus, and treated as 
day 0 of the estrous cycle.  At day 0, ewes were randomly assigned to Arg or saline (Sal) groups, 
and Arg or Sal injections were initiated at 0700 h.   
Jugular vein cannulations were conducted 5-7 days prior to day 0 of the estrous cycle. 
Neck wool was removed by shearing, the area was disinfected with betadine, and wiped with 
sterile gauze and 70% ethyl alcohol.  Approximately 10 minutes before cannulation, a local 
anesthetic (lidocaine HCl, 2%, sterile, Phoenix Scientific Inc., St. Joseph, MO) was injected 
subcutaneously into two sites (approximately 1 mL/site) along the jugular vein. The sheep were 
restrained manually, the skin was incised, and a sterile cannulation needle (12-gauge, Popper & 
Sons Inc., New Hyde Park, N.Y.) was inserted into the jugular vein, parallel to the trachea near 
the middle of the neck. Immediately after inserting the needle, a sterile cannula (outer diameter 
[O.D.] 2.16 mm, inner diameter [I.D.] 1.02 mm, Silastic Laboratory Tubing, DOW Corning 
Corporation, Midland, MI) was inserted through the needle into the jugular vein and the needle 
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was carefully removed. The length of the cannula was 25 cm (20 cm was inserted inside the 
jugular vein and 5 cm was allowed to remain outside). The cannula was flushed with sterile 
saline solution to make sure it was functional. The cannula was then filled with sterile heparin 
(sodium salt from porcine intestinal mucosa; Sigma, St. Louis, MO) in saline (300 IU of 
heparin/mL) solution and sealed with a sterile stopper. The outside portion of the cannula was 
attached to the skin via surgical tape, staples, and silicone glue. The skin around the cannula was 
washed to with sterile water, wiped with sterile gauze, and rinsed with 70% ethyl alcohol to 
remove traces of blood. 
Arginine or Saline Treatment  
Ewes in the Sal group received 5-10 mL three times daily of sterile saline solution, while 
ewes in the Arg group received a dose of 155 µmol Arg/kg BW three times daily (Sigma, St. 
Louis, MO) as previously described by Kaminski et al. (2015) in 5-10 mL via the jugular 
cannula.  Ewes received Arg or Sal for 15, 21, or 26 days.  Arg or Sal injections were initiated on 
day 0 of the estrous cycle and occurred three times daily (0700, 1400, 2100 h) until the end of 
experiment. After each injection, 1 cc of heparin solution was placed into the cannula to prevent 
blood from clotting within the tubing. 
Tissue and Blood Collection 
Ovaries and blood samples were collected at the early- or mid-luteal phase of the second 
estrous cycle, or late-luteal phase of the first estrous cycle.  These luteal stages correspond to day 
21, 26, or 15 of Arg or Sal.  Blood samples were centrifuged, and serum was stored at -20˚C 
until P4 analysis.  The number of CL was recorded, and CL were dissected from the ovary and 
weighed. Corpora lutea from each ewe was divided into four portions: the first portion was fixed 
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in 10% neutral buffered formalin (NBF) for immunohistochemistry, the second portion was fixed 
in Carnoy’s solution for immunohistochemistry, the third portion (approximately 20-50 mg) was 
immediately frozen on dry ice and stored at -80 C until homogenization in PBS (100 mg/1 ml), 
and the fourth portion (20-50 mg) was placed in 600 uL buffer RLT (Qiagen, Valencia, CA) in a 
nuclease-free 2.0 mL tube and homogenized using a 7 mm generator on a Polytron homogenizer 
for 10-15 seconds, then frozen on dry ice and stored at -80˚C prior to RNA extraction. 
Progesterone Analysis 
Progesterone concentrations from serum and homogenized luteal tissue were determined 
using a chemiluminescence immunoassay (Immulite 1000, Siemens), as previously described 
(Kaminski et al., 2015).  Briefly, a progesterone kit utilizes a solid phase, competitive 
immunoassay using enzyme-labeled chemiluminescent technology.  Each sample was run as 50 
µL duplicates. Beads coated with polyclonal rabbit anti-P4 antibodies are utilized for the initial 
solid phase.  Alkaline phosphatase conjugated to P4 is used for the liquid phase.  Samples and 
reagents are mixed and incubated for thirty minutes, during which sample P4 competes with 
enzyme-conjugated P4 in reagent for limited antibodies on the bead.  Centrifugal washes remove 
unbound sample and enzyme conjugate.  Lastly, chemiluminescent substrate is added and the 
luminescent signal that is generated is indicative of P4 concentration.  The intra-assay CV was 
6.9% for serum P4 and 5.2% for luteal P4. 
Immunohistochemistry  
All tissues were sectioned using a Leica rotary microtome (Leica RM 2255, Nussloch, 
Germany) and mounted on poly-L-lysine treated slides (Fisher Scientific, Pittsburg, PA).  Tissue 
sections were deparaffinized in xylene and rehydrated in decreasing concentrations of alcohol in 
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water and then washed in distilled water.  Tissue sections underwent antigen recovery (2100 
Retriever, Prestige Medical, Lancashire, England) for 20 minutes in a 10 mM sodium citrate 
buffer with 0.05 Tween (pH 6).  Slides were allowed to cool at room temperature for 20 minutes 
and then washed in TBST (0.1% Tween 20) twice for 5 minutes each.  Tissue sections were 
blocked with 10% normal goat serum for 20 minutes at room temperature.  Afterwards, tissue 
sections were incubated with a specific primary antibody followed by incubation with a 
secondary antibody.  Table 2.1 presents fixatives used, tissue thickness, and source and dilution 
of primary and secondary antibodies for all antigens immunodetected in this experiment.  Tissue 
sections were then washed twice for five minutes in distilled water at room temperature and 
cover slipped using Prolonged Gold with DAPI (Life Technologies, Eugene, OR). 
Image Generation and Analysis 
Photomicrographs were taken with a Zeiss Imager M2 epifluorescence microscope 
equipped with Zeiss piezo automated stage and AxioCam HRm camera (Zeiss Inc., Thornwood, 
NY).  All images were taken where distribution of steroidogenic and accessory cells is relatively 
uniform; areas with connective tissue tracts were avoided.  The percentage of area that exhibited 
positive fluorescent staining for CD31, Ki67, eNOS, or sGC was evaluated quantitatively with an 
image analysis system (Image Pro-Plus, Media Cybernetics, Silver Spring, MD) as described 
previously (Grazul-Bilska et al., 2006; Vonnahme et al., 2006).  For each CL, three randomly 
chosen fields were evaluated in each tissue section. 
 
 
  
 
 
  
Table 2.1. Tissue fixation, tissue section thickness, and antibodies used for immunohistochemistry to detect Ki67, 
CD31, eNOS, and sGC proteins in the CL. 
ANTIGEN PURPOSE FIXATIVE 
TISSUE 
THICKNESS 
1⁰ ANTIBODY, 
DILUTION, 
INCUBATION 
TIME 
2⁰ ANTIBODY, 
DILUTION, 
INCUBATION 
TIME REFERENCES 
CD31 
Endothelial 
cell marker  
NBF 15 µm 
CD31 rabbit 
polyclonal, item # 
ab28364, Abcam 
Biotech Company, 
San Fransisco, CA; 
1:100; overnight 
CF 633 goat anti-
rabbit, item # 
20122-0.5mL, 
Biotium, San 
Fransisco, CA; 
1:100;    1 hour 
Redmer et al., 2013 
Ki67 
Cell 
proliferation 
marker 
NBF 5 µm 
Ki67 mouse 
monoclonal, item # 
VP-k452, Vector 
Labs, Burlingame, 
CA; 1:100; 
overnight 
Alexa 568 goat anti-
mouse, item # 
A110040, Life 
Technologies, 
Carlsbad, CA; 
1:200; 1 hour 
Grazul-Bilska et al., 
2013; 2014 
eNOS 
Endothelial 
nitric oxide 
synthase 
marker 
Carnoy's 5 µm 
Anti-eNOS/NOS 
III purified mouse, 
item # 610297, BD 
Biosciences, San 
Jose, CA; 1:250; 
overnight 
Alexa 647 goat anti-
mouse, item # 
A21235, Invitrogen, 
Eugene, OR; 1:200: 
1 hour 
Grazul-Bilska et al., 
2006 
sGC 
Soluble 
guanylate 
cyclase 
marker 
NBF 5 µm 
Guanylate cyclase 
β rabbit polyclonal, 
item # 160897, 
Cayman Chemical, 
Ann Arbor, MI; 
1:500; 1 hour 
CF 633 goat anti-
rabbit, item # 
20122-0.5mL, 
Biotium, San 
Fransisco, CA; 
1:100;    1 hour 
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Background fluorescence was minimal and was adjusted to the same level for each section by the 
image analysis system.  Data were expressed as percentage of positive staining out of tissue area 
within each field.   
Quantitative Polymerase Chain Reaction (qPCR) 
TaqMan probe-primer sets (Applied Biosystems, Life Technologies Grand Island, NY) 
for 11 ovine genes (eNOS3, GUCY1B3, VEGF, PGF, FLT, KDR, ANGPT-1, ANGPT-2, Tie-2, 
FGF2 and FGFR) were used as previously described (Redmer et al., 2005; Grazul-Bilska et al., 
2013).  Quantifications of total RNA were completed via reading absorbance on a Synergy H1 
Microplate Reader (Bioteck, Winooski, VT).  Reverse transcription was utilized to produce 
cDNA (Quantitect RT Kit, Qiagen, Valencia, CA), from 1 μg of RNA.  Gene expression was 
determined (7500 Fast Applied Biosystem Instrument, Life Technologies, Grand Island, NY) and 
data was analyzed using the comparative CT method using 18s rRNA as the normalizing gene 
(Livak and Schmittgen, 2001). 
Statistical Analysis 
Data was analyzed as a 3x3x2 factorial, with interactions evaluated.  Data for BW, BCS, 
P4 concentration in serum and luteal tissues, CL weights, area of positive staining, and luteal 
angiogenic factor mRNA expression were analyzed using general linear model (GLM) 
procedures of SAS (SAS Institute Inc. 2011, Base SAS® 9.3 Procedures Guide. Cary, NC: SAS 
Institute Inc.).  When an F-test was significant, differences between specific means were 
evaluated by using least significant difference test (Kirk, 1982). Means were considered different 
when P<0.05.  Data are expressed as mean±SEM. 
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Results 
 
A summary of observed results are presented in Table 2.2.   
During nutritional and Arg treatments, C maintained BW and BCS, O gained 4.1±1.3 kg, 
and U lost 15.5±0.6 kg; for O, BCS increased by 1.1±0.1 and U decreased by 0.5±0.1.   
The CL number, and thus the ovulation rate, was greater (P<0.05) in O and C ewes when 
compared to U ewes and was not affected by Arg, and therefore combined data are presented 
(Fig. 2.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.2. Summary of effects of control (C), overfed (O), or underfed (U) plane of 
nutrition, arginine (Arg) or saline (Sal), early-(early), mid-(mid), or late-(late) estrous 
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phase, and their interactions on several measurements of reproductive function.   
Treatments Measurements* Observed change 
Nutritional 
Plane 
Ovulation rate 
Serum P4 concentrations 
(tendency) 
CD31 protein (tendency) 
Greater in O and C vs U  
Greater in O vs C or U 
 
Greater in C vs O or U 
Arginine  CD31 protein 
GUCY1B3 mRNA 
(tendency) 
Greater in Sal vs Arg  
Greater in Arg vs Sal 
Stage of the 
estrous cycle 
CL weight  
Serum and luteal P4  
CD31 protein  
Ki67 protein 
eNOS protein  
VEGF mRNA  
ANGPT2 mRNA 
Greater in mid and late vs early 
Greater in mid vs early or late 
Greater in early vs mid or late 
Greater in early vs mid vs late 
Greater in mid vs early or late 
Greater in early and mid vs late 
Greater at mid vs early or late 
Interactions 
Ki67 (nutrition by Arg by 
stage of luteal phase) 
 
eNOS mRNA (Arg by 
stage of luteal phase) 
 
 
KDR mRNA (nutrition by 
Arg by stage of luteal 
phase) 
Greatest in U and least in O in early 
treated with Arg 
 
Greater in Arg in mid in all nutrition 
groups 
 
 
Greatest in C and U vs O in mid 
treated with Arg  
 
*Measurements that were significantly (P<0.05) or tended (P<0.1) to be significantly 
affected are listed. 
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Figure 2.1. The number of CL in control (C), overfed (O), or underfed (U) ewes.  a,b P<0.05, 
means ±SEM with different superscripts differ.  
 
The CL weight was greater (P<0.0001) at mid- and late-luteal phase when compared to 
early-luteal phase, and was not affected by nutritional plane or Arg, and therefore combined data 
are presented (Fig. 2.2).  Serum P4 concentration was greater (P<0.0001) at mid-luteal phase 
when compared to early- or late-luteal phases (Fig. 2.3), tended to be greater (P=0.18) in O 
compared to U (1.7±0.2, vs. 1.4±0.2, respectively), and was intermediate in C (1.5±0.2).   
 
 
Figure 2.2. The weight of CL at early-, mid-, or late-luteal phases of the estrous cycle. a,b P<0.05, 
means ±SEM with different superscripts differ. 
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Figure 2.3. The concentration (ng/ml) of progesterone in serum at early-, mid-, or late-luteal 
phases of the estrous cycle. a,b P<0.05, means ±SEM with different superscripts differ. 
Concentration of P4 in luteal tissues was greater (P=0.001) in mid- than early- or late-
luteal phase (Fig. 2.4).  Serum and luteal tissue P4 concentrations were not affected by Arg.   
CD31 protein was immunodetected in luteal tissues and was localized to blood vessels 
throughout the estrous cycle (Fig. 2.5A, B).  CD31 protein expression was greater (P<0.0001) in 
early- compared to mid- or late-luteal phase (Fig. 2.5C).  Overall, compared to Sal, Arg 
decreased (P<0.02) CD31 expression and thus luteal vascularity; and CD31 expression tended 
(P=0.1) to be greater in C than U.  A tendency (P=0.09) for Arg, nutritional plane, and stage of 
the estrous cycle interactions demonstrated less CD31 expression in Arg ewes at the early-luteal 
phase in C ewes. 
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Figure 2.4. The concentration (μg/g of tissue) of progesterone in CL at early-, mid-, or late-luteal 
phases of the estrous cycle. a,b P<0.05, means ±SEM with different superscripts differ. 
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Figure 2.5. Representative images of CD31 (marker of vascularization) positive staining 
(purple) in an early- (A) and mid-luteal (B) phase CL, and expression of CD31 in CL from ewes 
at early, mid-, or late-luteal phases of the estrous cycle (C).  a,b P<0.05, means ± SEM with 
different superscripts differ.   
Ki67 protein was immunodetected in the nuclei of luteal cells throughout the estrous 
cycle (Fig. 2.6A, B, C).  Luteal cell proliferation was greatest (P<0.0001) during the early-luteal 
phase, less at mid-luteal phase, and least at the late-luteal phase (Fig. 2.6D).  A tendency 
(P=0.07) for Arg and stage of the estrous cycle interactions demonstrated greater cell 
proliferation in Arg ewes in the early-luteal phase compared to similarly treated ewes in the mid- 
or late-luteal phase of the estrous cycle in all nutritional groups.   
The eNOS protein was immunodetected and localized to blood vessels of the luteal tissue 
throughout the estrous cycle (Fig. 2.7A, B).  Expression of eNOS was greater (P<0.01) at mid-
luteal phase compared to at early or late-luteal phases, and was not affected by nutritional plane 
or Arg, therefore combined data are presented (Fig. 2.7C).  For eNOS mRNA, Arg by stage of 
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the estrous cycle interaction (P<0.04) demonstrated greater expression in Arg than Sal-treated 
ewes during the mid-luteal phase.   
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Figure 2.6.  Representative images of Ki67 (marker of vascularization) positive staining 
(yellow) in early- (A), mid- (B), and late-luteal (C) phase CL, control (D).  Non-proliferating 
cells stained purple (DAPI).  Labeling index (graph; percentage of Ki67 positive cells out of total 
cells/tissue area) in CL at early-, mid-, or late-luteal phases of the estrous cycle (E).  a,b,c P<0.05, 
means ± SEM with different superscripts differ. 
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Figure 2.7. Representative images of endothelial nitric oxide synthase (eNOS) positive (pink) 
staining in early- (A) and mid-luteal (B) phase CL.  Non-stained cells (blue; DAPI). Control 
slide (C).  eNOS protein staining (graph; % positive staining out of total tissue area) in the ovine 
CL at early- mid- or late-luteal phases of the estrous cycle. a, bP<0.05, means ±SEM with 
different superscripts differ. 
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The presence of sGC protein was immunodetected in luteal blood vessels (Fig. 2.8) and 
expression was similar in all groups (data not shown) throughout the estrous cycle.  GUCY1B3 
mRNA expression tended (P=0.09) to be greater in Arg ewes, but was not affected by nutritional 
plane or stage of the estrous cycle. In addition, interactions (P<0.02) between Arg and stage of 
the estrous cycle demonstrated an increased GUCY1B3 mRNA expression in luteal tissue from 
Arg compared to Sal ewes at the mid-luteal phase. 
 
Figure 2.8. Representative image of soluble guanylyl cyclase (sGC) positive staining (pink) in 
early-, mid-, and late-luteal phase CL (A).   
Expression of VEGF mRNA was greater (P=0.02) at early- and mid- compared to late-
luteal phase (Fig. 2.9) and was not affected by Arg or nutritional plane.  Expression of KDR and 
ANGPT2 mRNA was greater (P< 0.02) at the mid-luteal phase than at early or late-luteal phases 
and was not affected by Arg or nutritional plane therefore combined data are presented.  For 
KDR mRNA, nutritional plane by Arg by luteal phase interactions (P=0.05) demonstrated that in 
mid-luteal stage, expression was greater in 1) Arg than Sal C ewes, and 2) Arg C and U 
compared to O ewes treated with Arg (Fig. 2.10).  Expression of ANGPT2 mRNA was greater 
(P=0.01) in mid- compared to early- and late-luteal tissues (Fig. 2.11).  
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Figure 2.9. Vascular endothelial growth factor (VEGF) mRNA expression in CL at early-, mid-, 
or late-luteal phases of the estrous cycle.  a,b P<0.05, means ± SEM with different superscripts 
differ.   
 
Figure 2.10. KDR mRNA expression in CL at early-, mid-, and late-luteal phases of the estrous 
cycle in ewes treated with arginine (Arg) or saline (Sal) on control (C), overfed (O) or underfed 
(U) nutritional planes.  a, b, c P<0.05, means ± SEM with different superscripts differ.  
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Figure 2.11. Angiopoietin-2 (ANGPT-2) mRNA expression in CL at early-, mid-, or late-luteal 
phases of the estrous cycle.  a,b P<0.05, means ± SEM with different superscripts differ.   
Expression of ANGPT1, TIE2, FGF2, FGF2R, PGF, and FLT mRNA in luteal tissues 
was similar in all treatment groups and stages of the estrous cycle (data not shown).  
Discussion 
The present study demonstrates that nutritional plane and/or Arg affects several 
measurements of luteal function including ovulation rates, serum P4 concentrations, luteal 
vascularity and cell proliferation, and mRNA expression of eNOS and KDR. 
Ovulation rates were greater in O and C compared to U ewes. The association between 
nutritional plane and ovulation rate has been previously described by several researchers.  Prior 
studies have reported a positive correlation between higher BCS and ovulations rates (Gunn and 
Doney, 1975; Smith, 1995; Rhind et al., 1989; Xu et al., 1989; Abecia et al., 1997), and that 
lower BCS lead to low ovulation rates in the ewe (Keisler and Buckrell, 1997; Lassoued et al., 
2004).  When an animal is in a negative energy balance, the animal must use its own energy 
stores in an effort to reverse the energy deficit, resulting in negative effects on both the 
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hypothalamic-pituitary axis as well as the reproductive system (Scaramuzzi et al., 2006).  
Additionally, restricted nutritional planes lead to a multitude of hormonal imbalances including, 
but not limited to, elevated plasma growth hormone (GH), the inhibition of gonadotropin-
releasing hormone (GnRH), reduced ovulation rates, and even caused anovulation (Scaramuzzi 
et al., 2006).  Follicular populations and ovulation rates are reported to be very sensitive to 
nutritional plane alterations in the ewe (Scaramuzzi et al., 2006).  Therefore, adequate nutrition 
should be provided to an animal to achieve normal ovulation rate, and thus, lambing rates.  
Although our results concerning nutritional effects on ovulation rates in ewes are reflective of 
previous reports (Coop, 1966; Boland et al., 1988; O’Callaghan and Boland, 1999), our study 
demonstrated that ovulation rate was not affected by Arg supplementation.  We hypothesize, that 
supplements Arg is not involved in the regulation of ovulation rate in non-pregnant sheep.  
Further studies should be undertaken to elucidate the mechanism(s) of interactions between 
nutritional plane and ovulation rate.     
In this study, CL weight, serum P4 concentration, P4 luteal content, eNOS protein 
expression, and VEGF mRNA expression were greatest at the mid-luteal phase indicating normal 
luteal development and function (Stabenfeldt et al., 1969; Niswender and Nett, 1988; Grazul-
Bilska et al., 2006).  CL weight was not affected by nutritional plane or Arg, but serum P4 was 
greater in O than U ewes.  Similarly, Kaminski et al., (2015) observed increased serum P4 
throughout the estrous cycle in O ewes.  In contrast, increased serum P4 concentrations during 
the first estrous cycle on reduced nutrient intake in cows (Donaldson et al., 1970; Jordan and 
Swanson, 1979) and ewes (Cumming et al., 1971) have been reported.  However, if cows remain 
on a restricted nutritional intake, peripheral P4 concentrations are significantly reduced in later, 
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consecutive estrous cycles (Gombe and Hansel, 1973; Beal et al., 1978; Rodrigues et al., 2011).  
This subsequent decrease in P4 may be attributed to a further depletion in adipose tissue, and 
therefore adipose-stored P4.  It has been demonstrated that a considerable amount of P4 can be 
stored in adipose tissues and released into circulation if the fat is metabolized (Hamudikuwanda 
et al., 1996).  These findings could explain why the present study demonstrated a tendency for 
serum P4 to be lower in underfed ewes when compared to overfed ewes.  These ewes lost 15% 
of their initial BW, and thus fat storage was depleted, as reflected by decreased BW and BCS.  
Scaramuzzi et al. (2006) describes “negative and positive energy balances” to highlight the 
differences that occur between nutritional plane and reproduction.  When a ewe’s caloric 
requirement is greater than her intake, she is considered to be in a "negative energy balance”, 
while one that is consuming an excess of calories is considered to have a “positive energy 
balance”.  These changes to an animal’s metabolic state, and the underlying homeostasis, also 
affect reproductive performance.          
The present study demonstrated that CD31 expression, and therefore vascularity of the 
ovine luteal tissue was greatest at the early-luteal phase.  Similar data of luteal vascularity were 
previously reported for cow (Miyamoto et al., 2005) and primate (Fraser and Lunn, 2001).  In 
fact, 50 to 85% of the cells that are present as the growing CL are endothelial cells and pericytes 
(Christenson and Stouffer, 1996; Reynolds et al., 2000; Redmer et al., 2001).  During the early 
luteal phase, angiogenesis is quickly progressing in order to establish a blood vessel network 
(Reynolds et al., 2000).  The rapid microvasculature growth rate is critical for proper CL 
development and function, and inadequate ovarian blood supply has been associated with 
abnormal, decreased luteal function (Hazzard et al., 2002; Reynolds et al., 2000).  Furthermore, 
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decreased vascularity is characteristic for luteal regression during the late luteal phase 
(Knickerbocker et al., 1988; Reynolds et al., 2000; Vonnahme et al., 2006).   
In our study, Arg reduced vascularity at the early-luteal phase in C ewes.  However, 
studies regarding the cardiovascular system have demonstrated improvements of endothelial-
dependent vasodilation or blood pressure reduction after Arg-treatment to animal models or 
patients with cardiovascular disease (Girerd et al., 1990; Creager et al., 1992; Cooke et al., 1992; 
Clarkson et al., 1996; Palloshi et al., 2004; Dong et al., 2011). Since luteal vascularity was 
decreased in Arg C ewes at the early-luteal phase, endothelial cells may have prematurely 
senesced due to increased Arg concentration.  In fact, it has been reported that Arg could cause 
senescence of human endothelial cell in vitro (Scalera et al., 2009; Xiong et al., 2014).  However, 
decreased vascularity in Arg-treated ewes was not associated with changes in P4 secretion in this 
study, thus Arg did not affect the major luteal function.  Additional research is required to 
elucidate the association between Arg and endothelial cell function in the ovary.  
In the present study, cell proliferation was greatest in the early-, less at the mid-, and least 
at the late-luteal phase, which corresponds to luteal growth, differentiation and regression, 
respectively (Jablonka-Shariff et al., 1993).  In addition, pattern of cell proliferation was similar 
to vascular development during the estrous cycle.  The CL is one of the fastest growing tissues 
(Jablonka-Shariff et al., 1993) and within just a few days post-ovulation, the ovine CL can weigh 
more than 500 mg (Farin et al., 1986; Jablonka-Shariff et al., 1993).  
Similar to previous observations, eNOS protein was localized within luteal tissue 
vasculature in ewes in this study (Al-Gubory et al., 2005, Grazul-Bilska et al., 2006).  The 
current data demonstrate that eNOS protein expression was greatest at the mid-luteal phase when 
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compared to early- or late-luteal phase.  In contrast to our results, previous studies have reported 
greater eNOS protein expression in the CL from the early-luteal phase in sheep (Al-Gubory et 
al., 2005; Grazul-Bilska et al., 2006).  These differences are likely due to methodological 
differences including antibody sensitivity, detection technique (fluorescence vs colorimetric), 
and image analysis program.  Although eNOS expression was localized to luteal blood vessels, 
pattern of expression of CD31 (marker of vascularization) and eNOS differed.  We hypothesize 
that CD31 marks presence of the vascular bed and may not play any additional function in 
regulation of blood vessel function in the CL. In addition, since eNOS plays a regulatory 
function in the CL, its expression depends not only on the number of vascular cells but also on 
regulatory role. 
 In the current study, Arg affected luteal vascularity, as well as eNOS and GUCY1B3 
mRNA expression, depending on the stage of the estrous cycle.  Since Arg is a precursor for 
many components, including NO, supplementing Arg in excess could enhance NO production.  
In fact, several previous studies have demonstrated that NO production is primarily determined 
by extracellular Arg bioavailability in bovine (Hardy et al., 2002) and human (Xiong et al., 2014) 
endothelial cells, and that Arg administration for just 30 minutes results in an increase of NO 
production (Xiong et al., 2014).     
Luteal expression of GUCY1B3 mRNA but not sGC protein tended to be affected by Arg 
in our study.  However, neither was affected by plane of nutrition or stage of the estrous cycle.  
Grazul-Bilska et al. (2006) reported similar results, as GUCY1B3 mRNA expression was 
unchanged in luteal tissue throughout the estrous cycle.  It can be speculated that, since sGC is 
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the main receptor for NO, as serum Arg increased, the receptor gene expression increased as 
well.    
In the present study, VEGF mRNA expression was greatest at the early- and mid-luteal 
phase and VEGF receptor KDR mRNA expression was influenced by nutritional plane and Arg 
depending on the stage of the estrous cycle.  VEGF is an important regulator of blood vessel 
permeability, protease production, endothelial cell proliferation and migration to initiate 
angiogenesis, survival of endothelial cells, and normal blood vessel function (Alon et al., 1995; 
Ferrara and Davis-Smyth, 1997; Gerber et al., 1998).  We postulate that during the early-luteal 
phase specific concentration of VEGF expression is required to regulate angiogenesis, and 
during the mid-luteal phase VEGF may be required to control blood vessel permeability and 
endothelial cell function.  Our findings are similar to a previous studies, wherein VEGF and/or 
receptor KDR were detected in luteal tissues of women (Sugino et al., 2000), sow (Kaczmarek et 
al., 2006), water buffalo (Papa et al., 2006), cow (Berisha et al., 2000), mare (Al-zí abi et al., 
2003; Müller et al., 2009), monkey (Ravindranath et al., 1992; Fisher et al., 2013), and ewe 
(Redmer et al., 1996; Vonnahme et al., 2006).  Furthermore, increased VEGF mRNA expression 
during the mid-luteal phase was observed in women and mares (Al-zí abi et al., 2003; Papa et al., 
2006; Müller et al., 2009, respectively).  Inhibition of VEGF clearly demonstrated critical 
importance of the VEGF system for luteal function in several species (Ferrara et al., 1998; 
Kuhnert et al., 2008; Fraser et al., 2000; Zimmermann et al., 2001; Hazzard et al., 2002). In fact, 
VEGF inhibition resulted in decreased luteal vasularization, angiogenesis, endothelial cell 
proliferation and/or decreased P4 secretion in rats, mice and primates (Ferrara et al., 1998; 
Kuhnert et al., 2008; Fraser et al., 2000; Zimmermann et al., 2001; Hazzard et al., 2002).   
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In the present study, ANGPT2 mRNA expression was greatest at mid-luteal phase when 
compared to the early- or late-luteal phase, and expression of ANGPT1 mRNA was similar at all 
stages of luteal development.  Similarly, no change in ANGPT1 mRNA expression, but increased 
ANGPT2 mRNA expression was observed in ovine and bovine CL after PGF2α administration 
(Vonnahme et al., 2006; Berisha et al., 2010). 
Our hypothesis was based on previous observations for pregnant animals, demonstrating 
that Arg potentially benefitted placental function and increased the number of offspring born 
(Mateo et al., 2007; Zeng et al., 2008; Luther et al., 2009) and offspring body weights (de Boo et 
al., 2005; Lassala et al., 2010) in sheep and rats.  However, Arg to non-pregnant ewes, while 
changing luteal vascularity, demonstrated no change in ovulation rate, CL weight, or P4 
production.  The limited effects of Arg on ovarian function in the present study may be due to 
the fact that Arg is a semi-essential amino acid in non-pregnant animals.  Further research is 
required to determine potential Arg benefits in non-pregnant females.   
In summary, we have demonstrated that 1) nutritional plane affects ovulation rates, serum 
P4 concentrations, and KDR mRNA expression, 2) P4 concentrations, luteal tissue vascularity, 
cell proliferation, eNOS protein, and the VEGF system change during the estrous cycle, and 3) 
Arg affects luteal vascularity and the NO system during the estrous cycle.  These data indicate 
that plane of nutrition and/or Arg can alter P4 secretion, vascularization and expression of 
selected angiogenic factors in the CL during the estrous cycle.  In addition, our data further 
support previous observations that the VEGF and NO systems are involved in luteal function 
throughout the estrous cycle in sheep.   
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CHAPTER 3: ARGININE (ARG) EFFECTS ON EARLY EMBRYONIC 
DEVELOPMENT AND OOCYTE LIPID DROPLET CONTENT IN OVERFED AND 
UNDERFED SHEEP 
Abstract    
Plane of nutrition may affect reproductive function, including oocyte quality.  We have 
recently demonstrated that nutritional plane and/or in vivo arginine (Arg) supplementation (a 
precursor for proteins, nitric oxide and polyamines) affected selected ovarian functions such as 
ovulation rate and luteal function.  However, the effects of nutritional plane and in vitro Arg on 
ovine oocyte lipid droplet accumulation and ability to be fertilized have not been studied.  We 
hypothesized that high concentrations of Arg in maturation, fertilization, and culture media 
would affect function of oocytes collected from nutritionally compromised ewes.   Ewes (n = 43) 
were stratified by weight and randomly assigned to one of three nutritional groups: control (C, 
maintenance control), overfed (O, 2xC) or underfed (U, 0.6xC).  Control ewes were fed to 
maintain BW and offered 760 g/kg BW/day.  Each ewe was fed half her total pelleted diet 
individually twice daily.  Diets contained 2.4 Mcal of ME/kg and 13% crude protein (dry matter 
basis).  Estrus was synchronized by a 14-day treatment with CIDRs and estrus (day 0) was 
estimated to be approximately 36 h after CIDR removal.  Follicular development was induced by 
twice daily injections of follicle stimulating hormone (FSH) on days 13 and 14 of the estrous 
cycle.  On day 15 of the estrous cycle, the number of visible follicles was determined and 
oocytes were collected.  Cumulus oocyte complexes (COC) from two ewes of the same 
nutritional treatment were pooled (n=7-9 pools for each nutritional treatment) for in vitro 
maturation (IVM) and fertilization (IVF).  Half of the oocytes (n=16-30) from each pool were 
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incubated with low (0.004-0.247 mM) or high (2 mM) Arg concentrations in maturation, 
fertilization, and culture media.  During the ten week nutritional treatments, C maintained BW, O 
gained 13.2 ± 1.2 kg, and U lost 7.3 ± 0.7 kg. Increases in BCS were observed by 0.5 ± 0.1 and 
1.2 ± 0.1 for C and O ewes, respectively, but decreased by 0.3 ± 0.2 for U ewes.  The number of 
visible follicles was similar in all treatment groups.  On day four after IVM, accumulation of 
lipid droplets in unfertilized oocytes was determined using BODIPY staining followed by image 
analysis.  After IVF, developing embryos were evaluated throughout a six-day culture period.  
Lipid droplet accumulation was the greatest (P<0.0001) in O, less in C, and least in U (23.2 ± 
1.0, 17.0 ± 1.3 and 11.8 ± 0.7%, respectively), and high Arg tended (P<0.1) to increase (17.8 ± 
1.3 vs. 16.2 ± 1.3%) lipid droplet quantity regardless of nutritional plane.  Cleavage rate was less 
(P<0.03) in high than low Arg (53.2 ± 5.9 vs. 35.8 ± 5.1%), and was not affected by nutritional 
plane.  Morula formation rate was affected by a nutritional plane x high Arg interaction.  These 
data demonstrate that nutritional plane did not affect follicular development measured by the 
number of visible follicles, but affected accumulation of lipid droplets in oocytes, and morula 
formation rate.  Further, high Arg in medium decreases the rate of cleavage.  Thus, plane of 
nutrition affects oocyte function and quality, possibly through lipid droplet accumulation.  Also, 
high Arg during in vitro maturation, fertilization and early embryonic development has 
detrimental effects on oocyte quality.  The mechanism of regulation of oocyte function and 
quality by diet and/or Arg remains to be elucidated. 
Introduction 
 Assisted reproductive technologies (ART) over the last 20 years, have found many 
applications in agriculture (Grazul-Bilska, 2003).  Continuous progress has been made in modern 
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embryology in order to improve production of good quality oocytes and embryos.  The major 
ways leading to the improvements of in vitro embryo production are through improvements of 
culture conditions and/or quality of gametes through diet manipulation of donor animals.  Thus, 
numerous experiments have been performed to improve in vitro culture conditions for embryo 
production (Thompson, 1998; Guler et al., 2000; Rizos et al., 2002; Borowczyk et al., 2006; 
Grazul-Bilska et al., 2006).  In addition, numerous studies have been performed to evaluate the 
effects of specific plane of nutrition on reproductive performance to maintain high reproductive 
efficiency for several species including sheep and cows (O’Callaghan et al., 2000; Lozano et al., 
2003; Peura et al., 2003; Yaakub et al., 1999; Armstrong et al., 2001; Webb et al., 2004; 
Scaramuzzi et al., 2006; Grazul-Bilska et al., 2012). 
Proper oocyte function and quality, and early embryonic development are critical for 
embryonic survival (Krisher et al., 2003).  These processes are regulated by several intrinsic 
(e.g., hormones) and extrinsic (e.g., nutrition and other environmental factors) factors (Boland et 
al., 2001; Burdge et al., 2007; Wu et al., 2010; Grazul-Bilska et al., 2012; Castaneda et al., 
2013).  Nutrition during the periconception period has been demonstrated to influence 
reproductive outcomes such as changes in hormone production, oocyte lipid content, and 
fertilization rates (Robinson et al., 1990; Webb et al., 2004; Kakar et al., 2005; Borowczyk et al., 
2006; Castaneda et al., 2013; Grazul-Bilska et al., 2012).  However, contradictory results have 
been reported for the effects of a high or low nutritional plane on oocyte quality (Papadopoulos 
et al., 2001; Lozano et al., 2003; Borowczyk et al., 2006) and early embryonic development in 
livestock species (Mantovani et al., 1993; Creed et al., 1994; Nolan et al., 1998; Lozano et al., 
2003; Kakar et al., 2005; Grazul-Bilska et al., 2012; Rattay et al., 1980; Smith et al., 1983).  In 
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fact, researchers have reported positive, negative and no effect of plane of nutrition on oocyte 
quality and early embryonic development and differing results likely depended on duration of 
nutritional treatment, hormones used, animal breed, and/or culture conditions (McEvoy et al., 
1995; O’Callaghan et al., 2000; Boland et al., 2001; Lozano et al., 2003; Peura et al., 2003; 
Grazul-Bilska et al., 2012). 
 Arginine, which can be derived exogenously through the diet or endogenously via the 
intestinal-renal pathway, is a precursor for nitric oxide (NO), proteins, and polyamines (Wu et 
al., 2009, 2013). The NO system is involved in the regulation of oocyte development, 
angiogenesis, proper vascular function, ovulation, and luteolysis (Rosselli et al., 1998; Gregg et 
al., 2003; Wu et al., 2009; Zeng et al., 2013).  A few studies utilizing swine oocytes have 
demonstrated that Arg in media used for in vitro maturation, fertilization and/or embryo culture 
enhance oocyte developmental competence and/or early embryonic development (Hong and Lee, 
2007; Bauer et al., 2011).       
 The associations between nutrition, lipid content, and function of the oocyte have been 
identified for several species (Ferguson and Leese, 2006; Wu et al., 2010; Yang et al., 2012; 
Castaneda et al., 2013; Auclair et al., 2013; Crocco et al., 2013; Hiraga et al., 2013).  Nutritional 
plane affects lipid droplet accumulation or depletion within cells, including the mouse oocyte 
(Wu et al., 2010).  Lipids appear to be an important source of energy during oocyte growth, 
maturation and fertilization (Barcelo-Fimbres and Seidel, 2011; Jungheim et al., 2011; Aardema 
et al., 2013; Auclair et al., 2013; Castadena et al., 2013; Hiraga et al., 2013).  Furthermore, lipid 
accumulation in oocytes has been associated with developmental competence of oocytes in cows 
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and sows (Castaneda et al., 2013; Hiraga et al., 2013).  Lipid storage is reduced during the 
fertilization stage to formation of a two-cell embryo (Ferguson and Leese, 1999). 
Objectives and Hypothesis 
We hypothesized that high concentrations of Arg in maturation, fertilization and culture 
media will affect function of oocytes collected from ewes fed adequate (maintenance control), 
excess or restricted diets.  Therefore, the objective of this study was to evaluate the in vitro 
effects of Arg on oocyte lipid droplets accumulation, in vitro fertilization and early embryonic 
development in overfed to underfed FSH-treated ewes. 
Materials and Methods 
Animals and Experimental Design 
 All procedures performed were approved by the North Dakota State University 
Institutional Animal Care and Use Committee (#A12013).  The study commenced in August and 
ended in November, during the natural breeding season for sheep in the northern hemisphere.  
Non-pregnant, non-lactating Rambouillet ewes (n=43) between three to five years of age and of 
similar genetic background were individually penned at the Animal Nutrition and Physiology 
Center.  Ewes were stratified by weight and randomly assigned into one of three dietary 
treatments: control (C; n = 14) ewes received a maintenance diet (100% NRC requirements), 
overfed (O; n = 13) ewes received 2.0 x C, and underfed (U; n = 16) ewes were fed 60.6 x C 60 
days prior to the onset of the estrous cycle (day 0).  Ewes were fed half their individual diet twice 
daily (at 0800 h and 1500) and had ad libitum access to water.  For the duration of the 
experiment, body weights (BW) and body condition scores (BCS) were determined weekly.  
Diets were adjusted weekly to ensure the proper BW and BCS was achieved by day 0, and 
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maintained until completion of experiment on day 15 of the estrous cycle.  Estrus was 
synchronized by vaginal insertion of a controlled internal drug release (CIDR) device for 14 
days.  Based on previous results (Grazul-Bilska et al., unpublished), 36 h after CIDR removal, 
ewes were considered in estrus and treated as day 0 (d 0) of the estrous cycle.  All ewes were 
injected twice daily (morning and evening) with FSH (FSH-P; Sioux Biochemical, Sioux Center, 
IA, USA) on days 13 (5 mg/injection) and 14 (4 mg/injection) following estrus as described 
previously (Grazul-Bilska et al., 2012).  On day 15 of the estrous cycle, ovaries were collected, 
immersed in phosphate-buffered saline (PBS), and transported to the laboratory in an incubator 
(37-39°C).  
Oocyte Collection and Processing 
 Oocyte collection, processing, fertilization, and culture have been described in detail by 
Grazul-Bilska et al. (2003, 2006, 2012).  Briefly, the number of visible small (< 3mm) and large 
(>3mm) follicles on each ovary was determined and oocytes were isolated by opening each 
visible follicle with a sterile scalpel blade and flushing it two to three times with oocyte 
collection medium with heparin (Sigma, St. Louis, MO).  Under a stereomicroscope, oocytes 
were recovered from each dish and transferred to a petri dish containing fresh collection medium 
without heparin.  Oocytes were then evaluated and categorized as healthy or atretic based on 
their morphology (Grazul-Bilska et al., 2006, 2012).  Oocytes from two ewes of the same 
nutritional plane were combined and divided into two groups.  One group of oocytes was 
randomly allotted to incubation in maturation, fertilization and culture media with low Arg 
concentration (247.02, 4.41 and 49.59 µM, respectively), while the other oocyte group 
underwent the same procedures but in media with high Arg concentration (2-2.3 mM).  All 
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oocytes were then washed three times in maturation medium (TCM-199 containing 10% fetal 
bovine serum, ovine FSH [5 μg/ml; oFSH-RP-1; NIAMDD-NIH, Bethesda, MD], ovine LH [5 
μg/ml; oLH-26; NIADDK-NIH], estradiol [1 μg/ml; Sigma St. Louis, MO], glutamine [2 mM; 
Sigma], sodium pyruvate [0.25 mM; Sigma], epidermal growth factor [10 ng/ml; Sigma] and 
penicillin/streptomycin [100 units/ml penicillin and 100 μg/ml streptomycin]).  
In Vitro Maturation  
Oocytes were matured in vitro in maturation medium for 24 h at 39°C in 5% CO2 and 
95% air followed by cumulus cell removal using a solution of 1% (wt/vol) hyaluronidase (Type 
I; Sigma) in PBS.  The oocytes were again evaluated for health based on morphology. Oocytes 
classified as healthy were used for IVF and were transferred to fertilization medium consisting of 
synthetic oviductal fluid (SOF) prepared in our laboratory and 2% heat-inactivated sheep serum 
collected from sheep on day 0-1 of the estrous cycle. 
In Vitro Fertilization and Embryo Culture 
 Frozen capacitated semen from one Hampshire ram was thawed, and viable and unviable 
sperm were separated using the swim up technique.  Sperm (0.5-1.0x106 sperm/ml) were added 
to the IVF medium containing healthy oocytes and incubated for 18 h at 39ºC, 5% O2, 5% CO2 
and 90% N2.  The presumptive zygotes were washed three times with culture medium without 
glucose (SOF supplemented with BSA, glutamine, MEM amino acids, BME amino acids 
[Sigma] and penicillin/streptomycin) and cultured in fresh culture medium for 24 h at 39ºC, 5% 
O2, 5% CO2 and 90% N2.  The number of cleaved oocytes in each treatment group was 
determined and the embryos were transferred to culture medium containing glucose (1.5 mM).  
After 48 h, the developmental stage was evaluated and embryos were transferred to the fresh 
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culture medium with glucose.  The rate of cleavage (number of cleaved vs. non-cleaved oocytes), 
and the rate of early embryonic development (time and percentage reaching stage of morula) 
were evaluated every second day during a total of six days of culture.  Data was compared 
among treatment groups. 
Staining of Lipid Droplets and Image Analysis 
 Three days after IVF, all non-cleaved oocytes (n=1-7/culture) were separated from 
embryos.  Sperm was removed from oocytes by repeated pipetting with a 150 μm diameter 
micropipette.  Unfertilized, naked oocytes fixed in 10% formalin solution were stained with 
BODIPY (1 µg/ml; Molecular Probes; Eugene, OR) followed by staining with DAPI present in 
mounting media (ProLong; Life Technologies, Grand Island, NY).  Lipid droplets were 
visualized with BODIPY 493/503 using 488 nm excitation and 503 nm emission wavelengths.  
Images of oocytes were generated using a Zeiss Axiovision microscope (Carl Zeiss, Thornwood, 
NY).  Then, percentage of area occupied by lipid droplets out of the total oocyte area was 
determined by image analysis (ImagePro-Plus ver. 5.0 count module; Media Cybernetics, 
Rockville, MD).  
Statistical Analysis 
 Data was analyzed as a 3x3x2 factorial, with interactions evaluated.  All data are reported 
as mean ± SEM.  Data for BW and BCS, number of follicles and oocytes, and oocyte quality 
parameters (e.g., the rates of cleavage and morula formation) for control, overfed and underfed 
ewes were analyzed statistically by using the general linear models program of the Statistical 
Analysis System (SAS User’s Guide, 2014).  For all other parameters, the model included 
nutritional plane and Arg.  When F-tests were significant, differences between specific means 
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were evaluated by using Least Significant Difference test (Kirk, 1982).  In addition, data for the 
percentage of oocytes cleaved, and the rate of morula and blastocyst formation (%) were 
analyzed by using Chi-square analysis (SAS 2014). 
Results 
 During the 10-week nutritional treatments, C ewes maintained BW and BCS, while O 
ewes gained and U ewes lost BW and BCS (Table 3.1).  Plane of nutrition did not affect 
(P=0.15) the number of visible ovarian follicles (Table 3.1).  Cleavage rate was decreased 
(P<0.03) by high Arg, but was not affected by plane of nutrition (Table 3.2).  Morula formation 
tended (P=0.14) to be affected by plane of nutrition, being greater (P=0.14) in C and U than O 
group and was not affected by Arg (Table 3.2).  Accumulation of lipid droplets was affected 
(P<0.0001) by plane of nutrition, being greatest in O, less in C, and least in U ewes (Table 3.2, 
Figure 3.1) and was not affected by Arg (P=0.16).  
Table 3.1. Efects of nutritional plane on ovarian follicle number, and body weight (BW) 
and body condition score (BCS) for ewes. 
Measurement Control Overfed Underfed P value 
Number of ewes 14 13 16  
Total follicles 
(n) 
30.9 ± 2.8 26.4 ± 2.0 24.2 ± 2.4 0.150 
Initial BW (kg) 53.9 ± 1.4 55.0 ± 1.0 52.5 ± 2.0 0.552 
Final BW (kg) 55.9 ± 1.5a 68.2 ± 1.3b 45.2 ± 2.0c 0.0001 
Difference in 
BW (kg)** 
1.9 ± 0.8a 13.2 ± 1.2b -7.3 ± 0.7c 0.0001 
ADG (kg) 0.03 ± 0.01a 0.18 ± 0.02b -0.10 ± 0.01c 0.0001 
Initial BCS  2.7 ± 0.1 2.7 ± 0.1 2.6 ± 0.1 0.959 
Final BCS 3.1 ± 0.1a 3.9 ± 0.1b 2.3 ± 0.2c 0.0001 
Difference in 
BCS** 
0.5 ± 0.1a 1.2 ± 0.1b -0.3 ± 0.2c 0.0001 
All values (mean ± SEM) are expressed per ewe. 
**Difference between initial and final BW or BCS. 
 
  
 
 
 
 
   
Table 3.2. Effects of nutritional plane and arginine (Arg) or saline (Sal) treatment on cleavage and morula rates, and 
liquid droplet content in oocytes. 
Measurement 
Control3 Control+Arg Overfed3 Overfed+Arg Underfed Underfed+Arg Diet Arg 
Diet 
x 
Arg 
Number of 
cultures4 
7 7 8 8 9 9    
Oocytes for 
IVF (n) 
29.8 ± 
4.4 
30.4 ± 3.4 
18.1 ± 
2.4 
19.0 ± 2.8 
16.8 ± 
3.2 
18.4 ± 2.9 0.001 0.690 0.984 
Percent 
cleaved (%) 
60.4 ± 
8.0a 
32.8 ± 9.5bc 
45.3 ± 
8.8ac 
31.5 ± 9.8bc 
51.8 ± 
10.7ac 
41.9 ± 8.5ac 0.592 0.030 0.637 
Percent 
morula (%) 
36.0 ± 
9.9a 
22.2 ± 8.7abc 
19.1 ± 
12.0abc 
10.9 ± 4.4b 
32.7 ± 
10.2ac 
33.8 ± 10.3ac 0.140 0.386 0.742 
Lipid droplet 
content (%) 
15.7 ± 
1.1a 
17.0 ± 2.1ab 
22.4 ± 
1.7c 
23.9 ± 1.2c 
11.0 ± 
0.8d 
12.4 ± 1.1bd 0.0001 0.157 0.954 
*All values (mean ± SEM) are expressed per culture. 
1Ewes were fed a maintenance (control), overfed (2 x control), or underfed (0.6 x control) diet. 
2To determine lipid droplet content, unfertilized oocytes (n=1-7/culture) were fixed in formalin solution on day 3 after 
fertilization, and stained with BODIPY (1 µg/ml) followed by image analysis to determine percentage of positively 
stained area/oocyte. 
3Concentration of arginine in maturation, fertilization, and culture media was 247.02, 4.41, and 49.59 µM, respectively.  
For Arg-treatment groups, 2 mM of Arg (Sigma) were added.  Average concentration of Arg in follicular fluid was 
97.52 ± 22.4 µM. 
4For one culture, oocytes from two ewes of the same nutritional treatment were pooled. 
 a-dmeans±SEM; values with different superscripts differ within a row. 
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Figure 3.1. Representative image of BODIPY staining of lipid droplets (green) in a non-mature 
(GV stage; left) and a mature (MII stage; right) oocyte from a control ewe.  Oocyte DNA is 
stained with DAPI (blue). 
Discussion 
    The present study demonstrated that nutritional plane affected morula formation and lipid 
droplet accumulation in oocytes, while high Arg affected cleavage rate.  Furthermore, plane of 
nutrition did not affect the number of visible follicles.  Other researchers have also demonstrated 
that overfeeding and underfeeding ewes did not affect number of small or large follicles when 
compared to control fed ewes (Abecia et al., 1995, 1997; Peura et al., 2003; Borowczyk et al., 
2006; Grazul-Bilska et al., 2012).  Additionally, the number of follicles was similar in lactating 
dairy cows (not treated with FSH) that received a low or high energy diet for approximately 25 
weeks postpartum (Kendrick et al., 1999) and in yearling beef heifers (not treated with FSH) fed 
ad libitum or 0.75 x ad libitum for 100 days (Tripp et al., 2000).  Conversely, the association 
between nutritional plane and changes to follicular development has been previously described in 
ewes (Coop et al., 1966; Yaakub et al., 1997; O’Callaghan et al., 2000; Viñoles et al., 2010).  In 
addition, excess nutrition caused decreased follicle numbers recruited during follicular wave 
turnover in cattle (Stagg et al., 1995).  Researchers have postulated that overnutrition can cause 
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these changes due to altered endocrine profiles of FSH and E2, since a positive energy balance 
often results in abnormally high FSH secretions and reduced E2 concentrations (Scaramuzzi et 
al., 2006).  Abecia et al. (2006) hypothesized, “overfeeding during follicle recruitment and 
oocyte maturation imparts a legacy of embryonic loss and developmental retardation.”  
Undernutrition has also been associated with lower follicle numbers in cattle (Rhodes et al., 
1996; Robinson et al., 2006), as well as decreased ovulation rates in sheep (Lassoued et al., 
2004).  A negative energy balance causes inhibition of GnRH secretion from the hypothalamus, 
prevents FSH increases, and inhibits luteinizing hormone (LH) pulsatility (Scaramuzzi et al., 
2006).  While long-term feed restriction can cause anestrous in cattle due to insufficient 
circulating LH (Rhodes et al., 1995, 1996), short-term effects cause either decreased 
preovulatory surges of LH (Kiyma et al., 2004) or no changes to LH concentrations (Abecia et 
al., 1995).  Varying results of nutritional plane on follicle number reported could be due to 
dissimilarities in experimental design, such as different breeds, nutritional treatment lengths, 
and/or dietary compositions (Botkin et al., 1988; Grazul-Bilska et al., 2012). 
 In the present study, the high Arg concentration in medium decreased the rate of 
cleavage.  Silva et al. (2014) recently demonstrated similar detrimental effects of high Arg in 
IVF medium; a significant reduction in cleavage and blastocyst rates was observed when high 
Arg (50 mM) was added to medium.  Negative Arg effects on oocyte and cleavage rates may 
occur through increased NO production, as NO concentrations are primarily determined by 
extracellular Arg bioavailability (Hallemeesch et al., 2002; Hardy et al., 2002; Rajapakse et al., 
2009).  Previous studies have demonstrated the detrimental effects Arg can have on other cell 
types; for example, additional Arg to human endothelial cells for only 30 minutes increases NO 
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production (as detected by increased staining of 4,5-diaminofluorescein-2 diacetate [DAF-2DA], 
a marker of NO) and stimulates cell senescence (Xiong et al., 2014).  These high concentrations 
of NO can also lead to detrimental effects on the oocyte.  For example, high concentrations of 
sodium nitroprusside (SNP; a NO donor) in maturation medium have inhibited mouse oocyte 
meiotic development (Bu et al., 2003; Viana et al., 2006).  While high NO concentrations are 
detrimental to cells, others have demonstrated that the presence of NO can be beneficial or non-
harming to oocytes.  For example, low concentrations of SNP have had no stimulatory effects on 
bovine meiotic maturation (Viana et al., 2006) or stimulatory effects on mouse oocyte meiotic 
maturation (Bu et al., 2003).  Still yet, Goud et al. (2008) reported that NO actually extends the 
oocyte temporal window for fertilization while L-NAME decreased fertility, demonstrating the 
importance of NO presence in oocytes.  Similarly, the presence of NOS inhibitors during in vitro 
oocyte maturation reduced embryo development and quality in cows (Bilodeau-Goeseels, 2007; 
Schwarz et al., 2010), sows (Tao et al., 2004) and goat does (Amale et al., 2013).  These results 
have led researchers to hypothesize that NO can have opposing effects, dependent upon NO 
concentration; Bu et al. (2003) reported that NO at a concentration 30.69±5.06 µmol stimulated 
meiotic maturation of mouse oocytes, while a concentration of 59.88±8.07 µmol was inhibitory.   
 Morula formation was affected by nutritional plane but not by Arg in the present study, 
with greater morula formation in C and U than O.  Previous researchers have reported similar 
results, with the proportion of developing morula being less (Grazul-Bilska et al., 2012) or 
tending to be less (Borowczyk et al., 2006) in O and U ewe compared to C ewes.  In fact, several 
studies indicate that changes to nutritional plane, and therefore BCS, are associated with effects 
on early embryonic development (Snijders et al., 2000; Lozano et al., 2003).   
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  In our study, lipid droplet accumulation within unfertilized oocytes was affected by 
nutritional plane, similar to observations in cattle (Ferguson and Leese, 1999; Leroy et al., 2005), 
swine (Sturmey and Leese, 2003; Prates et al., 2013, 2014), mice (Wu et al., 2010), and women 
(Yang et al., 2012).  It has been suggested that a specific lipid composition within the oocyte is 
vital for proper preimplantation development (Sturmey and Leese, 2003; Lapa et al., 2011; Prates 
et al., 2014).  Lipid droplets are believed to be produced within the endoplasmic reticulum (ER), 
deposited within the ER membrane, and then join together to form a globule wherein they are 
covered by a cytoplasmic phospholipid monolayer (Suzuki et al., 2011).  Because lipid droplets 
are found in close proximity with organelles associated with cellular metabolism, for example 
mitochondria, ER, and endosomes (Ambruosi et al., 2009; Sturmey et al., 2006; Thiele and 
Spandl, 2008; Walther and Farese, 2009;), researchers have suggested that lipid droplets are used 
as an energy source for the oocyte (Sturmey and Leese, 2003; Sturmey et al., 2006; Gilchrist et 
al., 2008).  The amount of lipid droplets contained within the oocyte is believed to be critical to 
the changing metabolic pathways utilized by the oocyte and throughout early embryonic 
development (Ferguson and Leese, 1999; Sturmey and Leese, 2003; Prates et al., 2013).  During 
cleavage, the pentose phosphate pathway (PPP) is utilized; however, succeeding embryonic 
development preferentially uses glycolysis and β-oxidation, with the activity increasing during 
compaction and blastocyst formation (Sturmey and Leese, 2003; Gandhi et al., 2001; Swain et 
al., 2001).  Moreover, the varying lipid contents (higher in O and lower in U ewe oocytes 
compared to C ewe oocytes) observed in the present study and in previous studies (cited above) 
may account for the previously reported link between nutrition plane, cleavage rates, and early 
embryonic development (Grazul-Bilska et al., 2012).          
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 The present study demonstrated that 1) nutritional plane does not alter visible follicle 
number but can alter morula formation and lipid droplet accumulation in oocytes, and 2) high 
Arg concentration in medium decreased cleavage rates.  This data indicated that nutritional 
management is important to donor animals providing oocytes for assisted reproductive 
technologies (ART), as nutrition can impact both fertilization rates as well as early embryonic 
development, as demonstrated here.  Lastly, high Arg concentrations in medium are detrimental 
to fertilization rates and early embryonic development in ewes.  Future investigations addressing 
nutrition and/or specific medium supplements should provide insight into the underlying 
mechanisms associated with alterations in the efficiency of in vitro fertilization and early 
embryonic development.    
References 
 
Aardema, H., F. Lolicato, C. H. A. van de Lest, J. F. Brouwers, A. B. Vaandrager, H. T. A van 
Tol, B. A. J. Roelen, P. Vos, J. B. Helms, B. M. Gadella. 2013. Bovine cumulus cells 
protect maturing oocytes from increased fatty acid levels by massive intracellular lipid 
storage. Biol. Repro. 88: 164. 
 
Abecia, J. A., C. Sosa, F. Forcada, A. Meikle. 2006. The effect of undernutrition on the 
establishment of pregnancy in the ewe. Reprod. Nutr. Dev. 46: 367-78. 
 
Abecia, J. A., S. M. Rhind, T. A. Bramley, S. R. McMillen. 1995. Steroid production and LH 
 receptor concentrations of ovarian follicles and corpora lutea and associated rates of ova 
 wastage in ewes given high and low levels of food intake before and after mating. J. 
 Anim. Sci. 60: 57-62. 
 
Abecia, J. A., J. M. Lozano, F. Forcada, L. Zarazaga. 1997. Effect of level of dietary energy and 
 protein on embryo survival and progesterone production on day eight of pregnancy in 
 Rasa Aragonesa ewes. Anim. Reprod. Sci. 48: 209-18. 
 
Amale, M. H., A. Z. Shahne, S. Nasrollahi. 2013. Effects of nitric oxide synthase inhibition on 
 goat oocyte meiotic maturation. Arch. Tierz. 25: 255-63. 
 
Ambruosi, B., G. M. Lacalandra, A. I. Iorga, T. De Santis, S. Mugnier, R. Matarrese, G. Goudet, 
 134 
 
 
and M. E. Dell’Aquila. 2009. Cytoplasmic lipid droplets and mitochondrial distribution 
in equine oocytes: implications on oocyte maturation, fertilization and developmental 
competence after ICSI." Theriogenology. 71: 1093-104. 
 
Armstrong, D. G., T. G. McEvoy, G. Baxter, J. J. Robinson, C. C. Hogg, K. J. Woad, R. kakar, 
 K. D. Sinclair. 2001. Effect of dietary energy and protein on bovine follicular dynamics  
 and embryo production in vitro: associations with the ovarian insulin-like growth factor 
 system. Biol. Reprod. 64; 1624-32. 
 
Auclair, S., R. Uzbekov, S. Elis, L. Sanchez, I. Kireev, L. Lardic, R. Dalbies-Tran, S. Uzbekova. 
2013. Absence of cumulus cells during in vitro maturation affects lipid metabolism in 
bovine oocytes. Am. J. Pphysiol-Endoc. M. 304: E599-613. 
 
Barceló-Fimbres, M., G. E. Seidel. 2011. Cross-validation of techniques for measuring lipid 
content of bovine oocytes and blastocysts. Theriogenology. 75: 434-44. 
 
Bauer, B. K., L. D. Spate, C. N. Murphy, and R. S. Prather. 2011. Arginine Supplementation in 
vitro increases porcine embryo development and affects mRNA transcript expression. 
Reprod. Fert. Devel. 23: 107. 
 
Bilodeau‐Goeseels, S., M. Sasseville, C. Guillemette, F. J. Richard. 2007.  Effects of adenosine 
 monophosphate‐activated kinase activators on bovine oocyte nuclear maturation in 
 vitro. Mol. Reprod. Dev. 74: 1021-34. 
 
Boland, M. P., P. Lonergon, D. O’Callaghan. 2001. Effect of nutrition on endocrine parameters, 
ovarian physiology, and oocyte and embryo development. Theriogenology. 55: 1323-40. 
 
Borowczyk, E., J. S. Caton, D. A. Redmer, J. J. Bilski, R. M. Weigl, K. A. Vonnahme, P.  
P. Borowicz, J. D. Kirsch, K.C. Kraft, L. P. Reynolds, A. T. Grazul-Bilska. 2006. Effects 
 of plane of nutrition on in vitro fertilization and early embryonic development in sheep. J. 
 Anim. Sci. 84: 1593-9. 
 
Bu, S., G. Xia, Y. Tao, L. Lei, B. Zhou. 2003. Dual effects of nitric oxide on meiotic maturation 
of mouse cumulus cell-enclosed oocytes in vitro. Mol. Cell. Endocrinol. 207: 21-30. 
 
Burdge, G. C., M. A. Hanson, J. L. Slater-Jefferies, K. A. Lillycrop. 2007. Epigenetic regulation 
of transcription: a mechanism for inducing variations in phenotype (fetal programming) 
by differences in nutrition during early life. Brit. J. Nutr. 97: 1036-46. 
 
Castaneda, C. A., P. Kaye, M. Pantaleon, N. Phillips, S. Norman, R. Fry, J. D. Michael. 2013. 
Lipid content, active mitochondria and brilliant cresyl blue staining in bovine oocytes. 
Theriogenology. 79: 417-22. 
Coop, I. E. 1996. Effect of flushing on reproductive performance of ewes. J. Agr. Sci. 67: 305-
 23. 
 135 
 
 
 
Creed, J., T. G. McEvoy, J. J. Robinson, R. P. Aitken, R. M. Palmer, and I. Robertson. 1994. The 
effect of preovulatory nutrition on the subsequent development of superovulated sheep 
ova in an in vitro culture system. Anim. Prod. 58: 447. 
 
Crocco, M. C., Kelmansky, D. M., & Mariano, M. I. 2013. Does serum cause lipid-droplet 
accumulation in bovine embryos produced in vitro, during developmental days 1 to 4. J. 
Assist. Reprod. Gen. 30: 1377-88. 
 
Farese, R. V., T. C. Walther. 2009. Lipid droplets finally get a little RESPECT. Cell. 139: 855 
60. 
 
Ferguson, E.M., H. J. Leese. 2006. A potential role for triglyceride as an energy source during 
 bovine oocyte maturation and early embryo development. Mol. Reprod. Dev. 73:1195-
 201. 
 
Gandhi, A. P., M. Lane, D. K. Gardner, and R. L. Krisher. 2001. Substrate utilization in porcine 
embryos cultured in NCSU23 and G1. 2/G2. 2 sequential culture media. Mol. Reprod. 
Dev. 58: 269-75. 
 
Gilchrist, R. B., M. Lane, J. G. Thompson. 2008. Oocyte-secreted factors: regulators 
of cumulus cell function and oocyte quality. Hum. Reprod. Update. 14: 159-77. 
 
Goud, P. T., P. Anuradha, M. P. Goud, P. Diamond, B. Gonik, H. M. Abu-Soud. 2008. Nitric 
oxide extends the oocyte temporal window for optimal fertilization. Free. Rad. Biol. 
Med. 45: 453-9. 
 
Grazul-Bilska, A. T., E. Borowczyk, J. J. Bilski, L. P. Reynolds, D. A. Redmer, J. S. Caton,  
K. A. Vonnahme. 2012. Overfeeding and underfeeding have detrimental effects on 
oocyte quality measured by in vitro fertilization and early embryonic development in 
sheep. Domest. Anim. Endocrin. 43: 289-98. 
 
Grazul-Bilska, A. T., J. T. Choi, J. J. Bilski, R. M. Weigl, J. D. Kirsch, K. C. Kraft, L. P. 
Reynolds, and D. A. Redmer. 2003. Effects of epidermal growth factor on early 
embryonic development after in vitro fertilization of oocytes collected from ewes treated 
with follicle stimulating hormone. Theriogenology. 59: 1449-57. 
 
Grazul-Bilska, A. T., E. Borowczyk, W. Arndt, J. Evoniuk, M. O’neil, J. J. Bilski, R. M. Weigl, 
J. D. Kirsch, K. C. Kraft, K. A. Vonnahme, D. A. Redmer, L. P. Reynolds,  
and J. S. Caton. 2006. Effects of overnutrition and undernutritionn on in vitro  
fertilization (IVF) and early embryonic development in sheep. Biol. Reprod. 4: 579-87. 
 
Gregg, A. R. 2003. Mouse models and the role of nitric oxide in reproduction. Curr. Pharm. 
Design. 9: 391-8. 
 136 
 
 
 
Guler, A., N. Poulin, P. Mermillod, M. Terqui, and Y. Cognie. 2000. Effect of growth factors, 
EGF and IGF-I, and estradiol on in vitro maturation of sheep oocytes. Theriogenology. 
54: 209-18.  
 
Hallemeesch, M. M., W. H. Lamers, and N. E. P. Deutz. 2002. Reduced arginine availability and 
nitric oxide production. Clin. Nutr. 21: 273-9. 
 
Hardy, T. A., J. M. May. 2002. Coordinate regulation of L-arginine uptake and nitric oxide 
synthase activity in cultured endothelial cells. Free. Rad. Biol. Med. 32: 122-31. 
 
Hiraga, K., Y. Hoshino, K. Tanemura, E. Sato. 2013. Selection of in vitro-matured porcine 
oocytes based on localization patterns of lipid droplets to evaluate developmental 
competence. J. Reprod. Develop. 59: 405. 
 
Jungheim, E. S., G. A. Macones, R. R. Odem, B. W. Patterson, S. E. Lanzendorf, V. S. Ratts, K. 
H. Moley. 2011. Associations between free fatty acids, cumulus oocyte complex 
morphology and ovarian function during in vitro fertilization. Fertil. Steril. 95: 1970-4. 
 
Kakar, M. A., S. Maddocks, M. F. Lorimer, D. O. Kleemann, S. R. Rudiger, K. M. Hartwich, 
and S. K. Walker. 2005. The effect of peri-conception nutrition on embryo quality in the 
superovulated ewe. Theriogenology. 64: 1090-103. 
 
Kendrick, K. W., T. L. Bailey, A. S. Garst, A. W. Pryor, A. Ahmadzadeh, R. M. Akers, W. E. 
Eyestone, R. E. Pearson, and F. C. Gwazdauskas. 1999. Effects of energy balance on 
hormones, ovarian activity, and recovered oocytes in lactating Holstein cows using 
transvaginal follicular aspiration. J. Dairy. Sci. 82: 1731-41. 
 
Kiyma Z, B. M. Alexander, E. A. Van Kirk, W. J. Murdoch, D. M. Hallford, G. E. Moss. Effects 
of feed restriction on reproductive and metabolic hormones in ewes. J Anim Sci 2004, 82: 
2548-57. 
 
Krisher, R. L. 2003. The effect of oocyte quality on development. J. Anim. Sci. 82: E14-23. 
 
Lapa, M., C. C. Marques, S. P. Alves, M. I. Vasques, M. C. Baptista, I. Carvalhais, M. Silva 
Pereira, A. E. M. Horta, R. J. B. Bessa, and R. M. Pereira. 2011. Effect of trans‐10 cis‐12 
conjugated linoleic acid on Bovine Oocyte Competence and Fatty Acid Composition." 
Reprod. Domest. Anim. 46: 904-10. 
 
 
Leroy, J. L. M. R., Tom Vanholder, Bart Mateusen, Armand Christophe, Geert Opsomer, Aart de 
Kruif, Gaëtan Genicot, and Ann Van Soom. 2005. Non-esterified fatty acids in follicular 
fluid of dairy cows and their effect on developmental capacity of bovine oocytes in vitro. 
Reproduction. 130: 485-95. 
 137 
 
 
 
Lozano, J. M., P. Lonergan, M. P. Boland, D. O'Callaghan. 2003. Influence of nutrition on the 
effectiveness of superovulation programmes in ewes: effect on oocyte quality and post-
fertilization development. Reproduction. 125: 543-53. 
 
McEvoy, T. G., J. J. Robinson, R. P. Aitken, P. A. Findlay, R. M. Palmer, I. S. Robertson. 1995. 
Dietary induced suppression of pre-ovulatory progesterone concentrations in 
superovulated ewes impairs the subsequent in vivo and in vitro development of their ova. 
Anim. Reprod. Sci. 38; 89-107.  
 
Nolan, R., D. O'callaghan, R. T. Duby, P. Lonergan, and M. P. Boland. 1998. The influence of 
short-term nutrient changes on follicle growth and embryo production following 
superovulation in beef heifers. Theriogenology. 50: 1263-74. 
 
O’Callaghan, D., M. P. Boland. 1999. Nutritional effects on ovulation, embryo development 
and the establishment of pregnancy in ruminants. Anim. Sci. 68: 299-314. 
 
O'callaghan, D., H. Yaakub, P. Hyttel, L. J. Spicer, and M. P. Boland. 2000. Effect of nutrition 
and superovulation on oocyte morphology, follicular fluid composition and systemic 
hormone concentrations in ewes. J. Reprod. Fertil. 118: 303-13.  
 
Papadopoulos, S., P. Lonergan, V. Gath, K. M. Quinn, A. C. O. Evans,  D. O’Callaghan, M. P. 
Boland. 2001. Effect of diet quantity and urea supplementation on oocyte and embryo 
quality in sheep. Theriogenology. 55: 1059-69. 
 
Peura, T. T., D. O. Kleemann, S. R. Rudiger, G. S. Nattrass, C. J. McLaughlan, and S. K. 
Walker. 2003. Effect of nutrition of oocyte donor on the outcomes of somatic cell nuclear 
transfer in the sheep. Biol. Reprod. 68: 45-50. 
 
Prates, E. G., S. P. Alves, C. C. Marques, M. C. Baptista, A. E. M. Horta, R. J. B. Bessa, R. 
M. Pereira. 2013. Fatty acid composition of porcine cumulus oocyte complexes (COC) 
during maturation: effect of the lipid modulators trans-10, cis-12 conjugated linoleic acid 
(t10, c12 CLA) and forskolin. In. Vitro. Cell. Dev.-An. 49: 335-45. 
 
Prates, E. G., J. T. Nunes, R. M. Pereira. 2014. A role of lipid metabolism during cumulus 
oocyte complex maturation: impact of lipid modulators to improve embryo 
production.2014.  Mediators. Inflamm. 2014. 
 
Rajapakse, N. W., D. L. Mattson. 2009. Role of L‐arginine in nitric oxide production in health 
and hypertension. Clin. Exp. Pharm. Phys. 36: 249-55. 
Rhodes , F. M., K. W. Entwistle, J. E. Kinder. 1996. Changes in ovarian function and 
gonadotrophin secretion preceding the onset of nutritionally induced anoestrus in Bos 
indicus heifers. Biol Reprod. 55: 1437-43. 
 
 138 
 
 
Rhodes, F. M., L. A. Fitzpatrick, K. W. Entwistle, and G. De’ath. 1995. Sequential changes in 
ovarian follicular dynamics in Bos indicus heifers before and after nutritional anoestrus. 
J. Reprod. Fertil. 104: 41-9. 
 
Rizos, D., P. Lonergan, M. P. Boland, R. Arroyo-Garcia, B. Pintado, J. De La Fuente, A. 
Gutierrez-Adan. 2002. Analysis of differential messenger RNA expression between 
bovine blastocysts produced in different culture systems: implications for blastocyst 
quality. Biol. Reprod. 66: 589-95. 
 
Robinson, J. J. 1990. Nutrition in the reproduction of farm animals. Nutr. Res. Rev. 3: 253-276. 
 
Robinson, J. J., C. J. Ashworth, J. A. Rooke, L. M. Mitchell. T. G. McEvoy. 2006. Nutrition and 
fertility in ruminant livestock. Anim. Feed. Sci. Tech. 126: 259-76. 
 
Rosselli, Marinella, R. J. Keller, Raghvendra, K. Dubey. 1998. Role of nitric oxide in the 
biology, physiology and pathophysiology of reproduction. Hum. Reprod. Update. 4: 3-24. 
 
Scaramuzzi, R. J., B. K. Campbell, J. A. Downing, N. R. Kendall, M. Khalid, M. Munoz 
Gutierrez, A. Somchit. 2006. A review of the effects of supplementary nutrition in the 
ewe on the concentrations of reproductive and metabolic hormones and the mechanisms 
that regulate folliculogenesis and ovulation rate. Reprod. Nutr. Dev. 46: 339-54. 
 
Schwarz, K. R. L., P. R. L. Pires, T. H. C. de Bem, P. R. Adona, C. L. V. Leal. 2010. 
Consequences of nitric oxide synthase inhibition during bovine oocyte maturation on 
meiosis and embryo development. Reprod. Dom. Anim. 45: 75-80.  
 
Snijders, S. E., P. Dillon, D. O’Callaghan, M. P. Boland. 2000. Effect of genetic merit, milk 
yield, body condition and lactation number on in vitro oocyte development in dairy cows. 
Theriogenology. 53: 981-9. 
 
Stagg, K., M. G. Diskin, J. M. Sreenan, and J. F. Roche. 1995. Follicular development in long 
term anoestrous suckler beef cows fed two levels of energy postpartum. Anim. Reprod. 
Sci. 38:  49-61. 
 
Sturmey, R. G., H. J. Leese. 2003. Energy metabolism in pig oocytes and early embryos. 
Reproduction. 126: 197-204. 
 
 
Suzuki, M., Y. Shinohara, Y. Ohsaki, T. Fujimoto. 2011. Lipid droplets: size matters. J. Electron. 
Microsc. 60: S101-16. 
 
Swain, J. E., C. L. Bormann, R. L. Krisher. 2001. Development and viability of in vitro derived 
porcine blastocysts cultured in NCSU23 and G1. 2/G2. 2 sequential medium. 
Theriogenology. 56: 459-69. 
 139 
 
 
 
Tao, Y., Z. Fu, M. Zhang, G. Xia, J. Yang, H. Xie. 2004. Immunohistochemical localization of 
inducible and endothelial nitric oxide synthase in porcine ovaries and effects of NO on 
antrum formation and oocyte meiotic maturation. Mol. Cell. Endocrin. 222: 93-103. 
 
Thiele, C., J. Spandl. 2008. Cell biology of lipid droplets. Curr. Opin. Cell. Biol. 20: 378-85. 
 
Thompson, J. G., N. W. Allen, L. T. McGowan, A. C. S. Bell, M. G. Lambert, and H. R. Tervit. 
1998. Effect of delayed supplementation of fetal calf serum to culture medium on bovine 
embryo development in vitro and following transfer. Theriogenology. 49: 1239-49. 
 
Tripp, M. W., J. C. Ju, T. A. Hoagland, J. W. Riesen, X. Yang, and S. A. Zinn. 2000. Influence 
of somatotropin and nutrition on bovine oocyte retrieval and in vitro development. 
Theriogenology. 53: 1581-90. 
 
Viana, K. S., M.C. Caldas-Bussiere, S. G. C. Matta, M. R. Faes, C. P. de Carvalho, C. R. 
Quirino. 2007. Effect of sodium nitroprusside, a nitric oxide donor, on the in vitro 
maturation of bovine oocytes. Anim. Reprod. Sci. 102: 217-27. 
 
Webb, R., P. C. Garnsworthy, J. G. Gong, D. G. Armstrong. 2004. Control of follicular growth: 
Local interactions and nutritional influences1, 2. J Anim Sci. 82: E63-74. 
 
Wu, G., F. W. Bazer, M. C. Satterfield, X. L., X. Wang, G. A. Johnson, R. C. Burghardt, Z. Dai, 
J. Wang, Z. Wu. 2013. Impacts of arginine nutrition on embryonic and fetal development 
in mammals. Amino Acids. 45: 241-56. 
 
Wu, L. L. Y., Dunning, K. R., Yang, X., Russell, D. L., Lane, M., Norman, R. J., R. L. Robker. 
2010. High-fat diet causes lipotoxicity responses in cumulus–oocyte complexes and 
decreased fertilization rates. Endocrinology. 151: 5438-45.  
 
Wu, X., H. Ge, B. Lemon, J. Weiszmann, J. Gupte, N. Hawkins, X. Li, J. Tang, R. Lindberg, Y. 
Li. 2009. Selective activation of FGFR4 by an FGF19 variant does not improve glucose 
metabolism in ob/ob mice. P. Nat. Acad. Sci. 1064: 14379-84. 
 
Xiong, Y., M. F. Fru, Y. Yu, J. P. Montani, X. F. Ming, Z. Yang. 2014. Long term exposure to 
L-arginine accelerates endothelial cell senescence through arginase-II and S6K1 
signaling. Aging. Albany, NY. 6: 369. 
 
Yaakub, H., D. O'Callaghan, M. P. Boland. 1999. Effect of type and quantity of concentrates on 
superovulation and embryo yield in beef heifers. Theriogenology. 51: 1259-66. 
 
Yang, X., L. L. Wu, L. R. Chura, X. Liang, M. Lane, R. J. Norman, R. L. Robker. 2012. 
Exposure to lipid-rich follicular fluid is associated with endoplasmic reticulum stress and 
impaired oocyte maturation in cumulus-oocyte complexes. Fertil. Steril. 97: 1438-43. 
 140 
 
 
 
Zeng, X., X. Mao, Z. Huang, F. Wang, G. Wu, S. Qiao. 2013. Arginine enhances embryo 
implantation in rats through PI3K/PKB/mTOR/NO signaling pathway during early 
pregnancy. Reproduction. 145: 1-7. 
  
 141 
 
 
CHAPTER 4: PROGESTERONE SECRETION BY OVINE LUTEAL CELLS: 
EFFECTS OF NITRIC OXIDE, SELECTED METABOLIC HORMONES, AND PLANE 
OF NUTRITION 
Abstract 
The aim of this study was to investigate the role of the nitric oxide (NO) system and 
metabolic hormones on in vitro progesterone (P4) secretion by luteal cells from early and mid-
luteal phases of the estrous cycle from overfed and underfed ewes.  Ewes were randomly 
assigned to one of three nutritional groups: control (C; 760 g/kg BW/d; 100% NRC 
requirements), overfed (O; 2.0 x C), or underfed (U; 0.6 x C).  Superovulation was induced by 
follicle stimulating hormone (FSH) injections.  On d 5 or d 10 of the estrous cycle, corpora lutea 
(CL) were collected counted, dissected from ovaries, and luteal cells isolated enzymatically.  
Then, luteal cells were cultured with or without DETA-NONOate (NO donor), L-NAME (NO 
synthase [NOS] inhibitor), arginine (Arg), adiponectin, and leptin for 24 h in the presence or 
absence of LH.  The number of CL tended (P=0.09) to be greater in C and O ewes when 
compared to U ewes.  For experiment 1, 1.0 and 0.1 mM of DETA-NONOate inhibited (P<0.05), 
1.0 mM L-NAME+LH stimulated, and Arg, adiponectin, and leptin did not have any effects on 
basal P4 secretion by luteal cells from mid-luteal phase C ewes.  In experiment 2, we observed 
that 1) DETA-NONOate decreased basal and LH-stimulated P4 secretion by luteal cells, 2) L-
NAME increased basal and/or LH-stimulated P4 secretion by luteal cells depends on stage of 
luteal cells and nutritional plane, 3) Arg and adiponectin did not affect basal or LH-stimulated P4 
secretion in early luteal cells, and 4) leptin increased basal P4 secretion by luteal cells from d 5 
from C and U ewes, but did not affect LH-stimulated P4 secretion.  In summary, this study 
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demonstrated that nutritional plane affects ovulation rate in FSH-treated ewes, DETA-NONOate 
decreases P4 secretion, L-NAME increases P4 secretion, and that leptin but not Arg or 
adiponectin are involved in the regulation of P4 secretion by luteal cells during the estrous cycle 
in ewes fed different nutritional planes.  This study provides novel information since the effects 
of the NO system, Arg, and metabolic hormones on luteal cell function have not been studied in 
association with nutritional plane in any species.   
Introduction 
The CL forms after the oocyte is released from the antral cavity of the ovarian follicle 
during ovulation.  Besides being the main source for P4, proper formation of the CL is essential 
for pregnancy establishment and support, early embryonic development, and implantation in 
most mammalian species (Hodgen et al., 1988; Diaz et al., 2002; Murphy, 2004).  Throughout 
the duration of each non-pregnant estrous cycle, luteal tissues exhibit both structural and 
functional changes, such as changes in weight and P4 production (Jablonka-Shariff et al., 1993; 
Niswender and Nett, 1994; Smith et al., 1994; Grazul-Bilska et al., 1998; Reynolds et al., 2006).  
Both intrinsic (e.g., endocrine system, immune system, growth factors) and extrinsic (e.g., 
environment including nutrition) factors can influence CL function and production of P4 in 
livestock (Jablonka-Shariff et al., 1993; Niswender and Nett, 1994; O’Callaghan and Boland, 
1999; Grazul-Bilska et al., 2012; Kaminski et al., 2015).    
Nutritional plane can affect serum concentrations of both metabolic hormones (for 
example leptin and adiponectin) and reproductive hormones (such as P4), as well as ovulation 
rates in non-pregnant animals (Flier et al., 2000; Vasselli et al., 2013; Kaminski et al., 2015; 
O’Callaghan and Boland, 1999; Abecia et al., 1997; Parr et al., 1987; Armstrong et al., 2003; 
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Diskin et al., 2003).  In turn, altered metabolic and reproductive hormone concentration(s) may 
affect follicular and luteal functions (Armstrong et al., 2003; Scaramuzzi et al., 2006; Grazul-
Bilska et al., 2012). 
Nitric oxide, a reactive free radical generated from Arg via NOS, acts as a regulator for 
several physiological systems (Moncada et al., 1991) including reproduction (Jaroszewski and 
Hansel, 2000; Skarzynski et al., 2000; Jaroszewski et al., 2003; Korzekwa et al., 2006).  For 
several species, including cattle and sheep, it has been demonstrated that effectors of the NO 
system have direct effects on steroidogenesis in luteal tissues (Van Voorhtis et a., 1994; Vega et 
al., 1998; Mitsube et al., 1999; Dong et al., 1999; Skarzynski et al., 2000; Jaroszewski et al., 
2001, 2003; Hurwitz et al., 2002).  Bovine luteal cells from the mid-luteal phase treated with NO 
donors inhibited P4 production, while treatment with NOS inhibitors increased P4 production 
(Jaroszewski et al., 2001; Skarzynski and Okuda, 2000).  Similarly, treatment with an NO donor 
decreased and NOS inhibitor increased P4 production by granulosa cells from ewes fed different 
nutritional planes (Grazul-Bilska et al., 2015).  However, the role of the NO system, and 
metabolic hormones (adiponectin and leptin) in regulation of P4 secretion by luteal cells from 
ewes fed different nutritional planes has yet to be investigated in detail.   
Objectives and Hypothesis 
We hypothesized that effectors of the NO system, adiponectin, and leptin would affect P4 
production by luteal cells from the early- and mid-luteal phases of the estrous cycle from 
nutritionally compromised ewes.  Therefore, the objective of this study was to determine the 
effects of a NO donor (DETA-NONOate), a NOS inhibitor (L-NAME), Arg (precursor for NO), 
and metabolic hormones leptin and adiponectin, on basal and luteinizing hormone (LH)-
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stimulated P4 secretion by luteal cells from early- and mid-luteal phases obtained from 
nutritionally compromised, FSH-treated ewes.   
Materials and Methods 
Animals and Experimental Design 
All animal procedures performed were approved by the North Dakota State University’s 
Institutional Animal Care and Use Committee (#A12013).  The study was initiated during the 
normal breeding season in August and finished in December.   
Non-pregnant, non-lactating Rambouillet ewes (n = 31) between 3-5 years of age and of 
similar genetic background, were individually penned at the Animal Nutrition and Physiology 
Center on the NDSU campus.  Ewes were stratified by weight and randomly assigned into one of 
three dietary treatments: control (C; n = 9) received a maintenance diet (100% NRC 
requirements), overfed (O; n = 12) received 200% NRC requirements, and underfed (U; n = 10) 
received 60% NRC requirements 60 days prior to the onset of the estrous cycle (d 0).  Ewes were 
fed half of their individual diet daily at 0800 and the remaining half at 1500.  Ewes were 
weighed once weekly for the duration of the experiment.  Diets were adjusted weekly for each 
ewe to ensure the proper nutritional plane was achieved at d 0, and maintained throughout the 
estrous cycle until completion of experiment on d 5 or d 10 of the second estrous cycle. The 
nutritional treatment is described in detail by Kaminski et al. (2015). 
Estrus was synchronized by insertion of a controlled internal drug release (CIDR) device 
for 14 days.  Based on previous results (Grazul-Bilska et al., unpublished), approximately 36 h 
after removal of the CIDR ewes were considered in estrus and treated as d0 of the estrous cycle.  
Ewes were injected twice daily (morning and evening) with follicle stimulating hormone (FSH-
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P; Sioux Biochemical, Sioux Center, IA, USA) on d 13, d 14, and d 15 of the estrous cycle (5 
mg/injection, 4 mg/injection, or 3 mg/injection, respectively) (Grazul-Bilska et al., 2012). 
Tissue and Blood Collection 
On d 5 or d 10 of the estrous cycle ovaries were collected, immersed in PBS and 
transported to the laboratory.  Then, CL were counted and dissected from ovaries, weighed, and 
minced for dissociation with collagenase (Sigma, St. Louis, MO) as previously described 
(Grazul-Bilska et al., 1991, 2001).  Blood samples were also collected on d 5 or d 10, centrifuged 
(20 min at 1,500g), and serum was stored at -20˚C until P4 analysis.   
Dissociation of Luteal Cells 
Minced luteal tissues were incubated in dissociation medium containing Hank’s balanced 
salt solution (HBSS; Gibco, Grand Island, NY) and collagenase (0.01% wt/vol), bovine serum 
albumin (BSA; 2%, wt/vol; Sigma, St. Louis, MO), penicillin (100 U/mL; Gibco, Grand Island, 
NY), and streptomycin (100 µgmL; Gibco, Grand Island, NY) in a shaking (100 cycles/min) 
water bath at 37 C in a capped 50-mL Erlenmeyer flasks.  After initial 15 min incubation, 
medium containing dispersed luteal cells was aspirated, and 2-3 mL of fresh dissociation 
medium was added to the remaining tissue.  After this initial collection and replacement, medium 
was aspirated and replaced every 7-10 minutes for ~10 incubations.  This process was continued 
for approximately 3 h, or until luteal tissues were completely dissociated.  At the end of 
collection, medium containing dispersed luteal cells was centrifuged (600 x g) for 5 min.  The 
pellet was washed three times with HBSS containing antibiotics (100 U penicillin and 100 µg 
streptomycin/mL) and then resuspended in the same medium via trituration with a siliconized 
Pasteur pipette.  The cell suspension was filtered through a sterile nylon filter with 70 µm pores 
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(Tetko, New York, New York) to remove pieces of tissue and then centrifuged (300 x g; 10 min).  
Cells were resuspended in Dulbecco’s Modified Eagle Medium (DMEM; Gibco, Grand Island, 
NY) plating medium containing 10% (vol/vol) calf serum (CS; Gibco, Grand Island, NY), 10% 
fetal bovine serum (FBS; Gibco, Grand Island, NY) and antibiotics (100 U penicillin and 100 µg 
streptomycin/mL).  Luteal cells were counted using a hemocytometer and viability was evaluated 
by trypan blue (Gibco, Grand Island, NY) exclusion.  The viability of freshly dispersed luteal 
cells was 87.1±2.4% and the proportion of large luteal cells in the total steroidogenic cell 
population was 8.25±1.6% for early and mid-luteal phases for all nutrition treatments.  
Experiment 1  
For the dose-response experiment, freshly dissociated luteal cells from d10 of the estrous 
cycle from control ewes (n = 4) were plated at a concentration of 250,000/well/ml with DMEM 
containing 10% FBS and 10 % CS at 37⁰ C in 5% CO2 in humidified air for 24 h.  After plating, 
media were changed to serum-free DMEM with penicillin/streptomycin (0.5 ml/well) and 
incubated for 24 h at 37⁰ C in 5% CO2 in humidified air in the presence or absence of the 
following treatments: DETA-NONOate (0.01, 0.1, or 1.0 mM; Cayman, Ann Arbor, MI, USA), 
L-NAME (0.1 or 1.0 mM; Cayman), Arg (1 or 2 mM; Sigma, St. Louis, MO), adiponectin (1, 3, 
or 10 µg/mL; BioVendor, Ashville, NC), and leptin (1.0, 10, or 100 ng/mL; RayBiotech Inc., 
Norcross, GA).  In addition, cells were incubated in the presence of LH (100 ng/mL; oLH-26; 
NIAKKK-NIH, USA) in media containing DETA-NONOate (0.01 mM), L-NAME (1 mM), Arg 
(1 or 2 mM), adiponectin (3 µg/mL), and leptin (10 ng/mL).  Treatment with dbcAMP (1 mM; 
Sigma) was used as a positive control.  As additional controls, DMSO (less than 1%; diluting 
factor for DETA-NONOate), DETA (1 mM; analog of the DETA-NONOate; Dow Chemical 
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Company, Midland, MI, USA), and D-NMME (1 mM; analog of L-NAME; Cayman) were used.  
Media were then collected for P4 analysis.  
Experiment 2  
Isolated luteal cells from d 5 and d 10 of the estrous cycle from C, O and U ewes were 
plated at a concentration of 250,000/well/ml with DMEM containing 10% FBS and 10 % CS at 
37⁰ C in 5% CO2 in humidified air for 24 h. Media then were changed to serum-free DMEM 
with penicillin/streptomycin (0.5 ml/well) and cells were incubated for 24 h at 37⁰ C in 5% CO2 
in humidified air with or without DETA-NONOate (1.0 mM), L-NAME (1.0 mM), arginine (1, 
mM), leptin (10 ng/mL), and adiponectin (3µg/mL), in the presence or absence of LH (100 
ng/ml).  Additional controls were used as described for experiment 1 above.  Media were then 
collected for P4 analysis.   
Progesterone Analysis 
Progesterone concentrations from serum and media were determined using a solid phase 
chemiluminescence, competitive binding immunoassay (Immulite 1000, Siemens), as previously 
described (Grazul-Bilska et al., 2014; Kaminski et al., 2015).  Each sample was run as 50 µL 
duplicates. Beads coated with polyclonal rabbit anti-P4 antibodies were utilized for the initial 
solid phase.  Alkaline phosphatase conjugated to P4 is used for the liquid phase.  Samples and 
reagents are mixed and incubated for thirty minutes, during which time sample P4 competes with 
reagent enzyme-conjugated P4.  Centrifugal washes remove unbound sample and enzyme 
conjugate.  Lastly, chemiluminescent substrate is added and the signal that is generated is 
indicative of P4 concentration.  The intra-assay CV for P4 in media was 14.3%. 
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Statistical Analysis 
Data were analyzed using the GLM program of SAS.  When the F-test was significant (P 
≤ 0.05), means were separated by using least significant differences.  
Results 
Initial BW and BCS were similar for all groups (56.3±1 kg and 2.8±0.05, respectively). 
During study duration, C maintained BW and BCS, O ewes gained (P<0.001) 15.8±1 kg and 
BCS increased to 3.2±1, and U ewes lost (P<0.001) 11.2±1 kg and BCS decreased to 2±0.1, 
similar to our previous studies (Borowczyk et al., 2006; Grazul-Bilska et al., 2012; Kaminski et 
al., 2015).  The number of CL tended (P=0.09) to be greater in C and O ewes when compared to 
U ewes (12.5±1.8, 12.3±2.1, 7.3±0.6, respectively).  Serum P4 was greater (P<0.05) in d10 
compared to d5 luteal cells (14.0±2.8 ng/mL and 7.0±1.2 ng/mL, respectively), but was not 
affected by nutritional plane. 
Experiment 1 
The dose-response experiment demonstrated that 1.0 mM and 0.1 mM doses of DETA-
NONOate were inhibitory, while 0.01 mM of DETA-NONOate or LNAME (either 1.0 or 0.1 
mM doses) did not affect basal P4 secretion (Fig. 4.1).  P4 secretion by luteal cells was increased 
~2-fold in the presence of LNAME+LH.  In addition, neither Arg, leptin nor adiponectin affected 
basal or LH-stimulated P4 secretion by luteal cells (data not shown). 
Experiment 2 
Basal P4 secretion by luteal cells was greater (P<0.0001) on d10 when compared to d5 
(18.3±2.4 ng/mL and 4.6±1.0 ng/mL, respectively; Fig. 4.2).  However, plane of nutrition did not 
affect basal P4 concentrations.  DETA-NONOate decreased (P<0.0001) basal and LH-stimulated 
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P4 secretion by luteal cells from d 5 and d 10 of the estrous cycle from all nutritional groups 
(range 0.42-fold -0.74-fold; Fig. 4.3), whereas, L-NAME increased (P<0.0001) basal P4 
secretion by luteal cells from d 5 and d 10 of the estrous cycle from all nutritional groups with 
the exception of cells from d 5 in C and d 10 in O ewes (1.18 ± 0.06 and 1.28 ± 0.04, 
respectively; Fig. 4.3).  In addition, L-NAME enhanced (P<0.05) LH-stimulated P4 secretion by 
luteal cells from d5 and d10 of the estrous cycle in C, and d 5 in U ewes (Fig. 4.3).  Arg and 
adiponectin did not affect basal or LH-stimulated P4 secretion by luteal cells from any day of the 
estrous cycle in any nutritional group (Fig. 4.3).  Leptin increased basal P4 secretion by luteal 
cells from d 5 from C and U ewes, but did not affect LH-stimulated P4 secretion by luteal cells 
from any day of the estrous cycle in any nutritional group.  Secretion of P4 by luteal cells from 
d5 and d10 of the estrous cycle was increased (P<0.0001) by dbcAMP (range 1.6-1.8-fold) in all 
nutritional groups (Fig. 4.3).   
Discussion 
This study demonstrated that nutritional plane affected ovulation rates but did not have 
any effects on in vitro P4 secretion by luteal cells from early and mid-luteal phases of the estrous 
cycle.  The number of CL, and thus ovulation rates, tended to be greater in C and O compared to 
U ewes after FSH-induced superovulation in our study. 
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Figure 4.1. The effects of DETA-NONOate (1.0, 0.1, or 0.01 mM) and LH + L-NAME (1.0 
mM) dose response on P4 secretion from d 5 luteal cells collected from control ewes.  * indicates 
P<0.05 compared to 1 (bold line).  
 
 
Figure 4.2. Basal progesterone (ng/mL) secretion from d 5 compared to d 10 luteal cells for 
control (C), overfed (O), and underfed (U) ewes.  The basal P4 concentration in media was 
4.6±1.0 ng/mL and 18.3±2.4 ng/mL on d5 and d10 of the estrous cycle, respectively. Data are 
combined for C, O, and U ewes because diet did not affect basal P4 secretion at any day.  
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Day 5 
 
 
 
Figure 4.3. The effects of DETA-NONOate (detaNO; NO donor), L-NAME (lname; NOS 
inhibitor), arginine (arg), leptin (lep) and adiponectin (adipo) on basal and LH (lh)-stimulated P4 
secretion by luteal cells from d 5 of the estrous cycle from control, overfed and underfed ewes 
treated with follicle stimulating hormone (FSH).  Dibutyryl cyclic adenosine monophosphate 
(dbcAMP), a factor that stimulates P4 secretion by luteal cells was used as a positive control, and 
DETA and D-NMME were used as controls for DETA-NONOate and L-NAME, respectively.  
Data are expressed as fold-change compared to cultures with no treatment (no treatment 
arbitrarily set as 1, and marked as a bold line).  Basal P4 concentration in media was 4.6±1.0 
ng/mL and 18.3±2.4 ng/mL on d 5 of the estrous cycle, respectively.  a-fP<0.05; values with 
different superscripts differ. * indicates P<0.05 compared to control set as 1 (bold line). 
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Day 10 
 
 
 
Figure 4.4. The effects of DETA-NONOate (detaNO; NO donor), L-NAME (lname; NOS 
inhibitor), arginine (arg), leptin (lep) and adiponectin (adipo) on basal and LH (lh)-stimulated P4 
secretion by luteal cells from d 10 of the estrous cycle from control, overfed and underfed ewes 
treated with follicle stimulating hormone (FSH).  Dibutyryl cyclic adenosine monophosphate 
(dbcAMP), a factor that stimulates P4 secretion by luteal cells was used as a positive control, and 
DETA and D-NMME were used as controls for DETA-NONOate and L-NAME, respectively.  
Data are expressed as fold-change compared to cultures with no treatment (no treatment 
arbitrarily set as 1, and marked as a bold line).  Basal P4 concentration in media was 4.6±1.0 
ng/mL and 18.3±2.4 ng/mL on d 10 of the estrous cycle, respectively.  a-fP<0.05; values with 
different superscripts differ. * indicates P<0.05 compared to control set as 1 (bold line). 
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In non-stimulated ewes, we have also observed lower ovulation rates in U than C and O 
ewes (see Chapter 2).  The association between nutritional plane and ovulation rate have also 
been reported for ewes by other researchers; for example higher BCS correlated positively with 
ovulations rates (Gunn and Doney, 1975; Smith, 1995; Rhind et al., 1989; Xu et al., 1989; 
Abecia et al., 1997), and lower BCS lead to low ovulation rates in the ewe (Keisler and Buckrell, 
1997; Lassoued et al., 2004).  Scaramuzzi et al. (2006) explained that when an animal is in a 
negative energy balance, the animal must use its own energy stores in an effort to reverse the 
energy deficit, resulting in negative effects on both the hypothalamic-pituitary level as well as 
the reproductive system leading to decreased ovulation rates.  Additionally, restricted nutritional 
planes lead to a multitude of hormonal imbalances including, but not limited to, elevated plasma 
growth hormone (GH), the inhibition of gonadotropin-releasing hormone (GnRH), reduced 
ovulation rates, and even anovulation (Scaramuzzi et al., 2006).  Follicular populations and 
ovulation rates are reported to be very sensitive to nutritional plane alterations in the ewe 
(Scaramuzzi et al., 2006).  Thus, optimal nutritional plane should be considered to achieve 
normal ovulation rates, and therefore, lambing rates. 
The current study supports previous reports that both serum and basal P4 secretion by 
ovine luteal cells were greater at d10 when compared to d5 of the estrous cycle (Borowczyk et 
al., 2007).  The CL growth phase lasts eight to ten days in ewes and is parallel to increasing P4 
production (Reynolds et al., 2002; Murphy et al., 2004).  There are major changes within the 
functional CL in the expression of proteins that make up both high-density lipoprotein (HDL), 
and LDL cholesterol importation pathways during luteinization (Plotkin et al., 2002; Niswender 
et al., 2002).  In fact, cholesterol transportation to the inner mitochondrial membrane is the rate-
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limiting step in P4 biosynthesis (Murphy et al., 2004).  These synergistic changes, along with 
alterations in other processes within the CL, allow for high secretion of P4 by luteal cells in the 
mid-luteal phase.    
The present study demonstrates that the NO donor DETA-NONOate decreased both basal 
and LH-stimulated P4 secretion by ovine luteal cells in ewes from early and mid-luteal phase in 
all nutrition groups. Similar, the in vitro treatment with NO donors (sodium nitroprusside, S-
nitroso-N-acetyl-DL-penicillamine, or spermine NONOate) of bovine luteal cells from the mid-
luteal phase resulted in inhibition of P4 production (Skarzynski and Okuda, 2000; Jaroszewski et 
al., 2001).  In addition, we have recently demonstrated that DETA-NONOate (NO donor) 
decreased P4 production by ovine granulosa cells in vitro (Grazul-Bilska et al., 2015).  Our 
findings support previous reports that NO donors decrease P4 secretion by luteal cells, and in 
addition, demonstrate that nutritional plane does not affect NO inhibitory effects on luteal 
function during the estrous cycle.      
Our present experiment confirmed results from previous in vitro studies demonstrating 
the inhibition of NO production via a nonselective NOS inhibitor, L-NAME results in increased 
basal P4 secretion by luteal cells from rabbits (Gobbetti et al., 1999) and cows (Skarzynski and 
Okuda, 2000; Jaroszewski et al., 2003; Korzekwa et al., 2004).  Similar, L-NAME enhanced in 
vitro P4 secretion by granulosa cells from ewes fed different nutritional planes (Grazul-Bilska et 
al., 2015).  Researchers utilizing NOS inhibitors in vivo reported that in vivo infusion of a NOS 
inhibitor at mid- and late-luteal phase in cows not only increased P4 secretion, but that it also 
increased the functional life of the CL (Jaroszewski et al., 2000; Skarzynski et al., 2003).  It has 
been postulated that the administration of PGF2α can cause an acute increase in blood flow in the 
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CL (Acosta et al., 2002), enhancing NO production from luteal endothelial cells (Korzekwa et 
al., 2004).  The increase in NO production from the mid- and late-luteal phase CL after the first 
few hours post- PGF2α may induce functional luteolysis including further blood flow changes to 
the CL and a decrease in P4 production (Skarzynski et al., 2003; Jaroszewski et al., 2000, 2003).   
Arg did not affect P4 production by luteal cells at any day of the estrous cycle and any 
nutritional group.  While Arg can be acquired exogenously through the diet, 40% of dietary Arg 
is catabolized by the small intestine before it can enter the blood stream (Wu and Morris, 1998).  
The majority of endogenously acquired Arg is derived from the intestinal-renal pathway.  Within 
the small intestine, the enterocyte is responsible for citrulline or arginine synthesis from 
glutamine and glutamate (Wu and Knabe, 1995); these precursors are then catabolized by the 
small intestine (Windmueller and Spaeth, 1975), both being major precursors for endogenously 
synthesized Arg (Wu, 1998).  While Arg is a precursor for NO, it is also necessary for 
polyamines, creatine, and agmatine production, all of which have enormous biological 
importance (Wu et al., 2009; Lefèvre et al., 2011). Further studies should be undertaken to 
determine if Arg and their derivatives may have additional effects on luteal function. 
We observed that leptin increased basal P4 secretion by luteal cells from the early luteal 
phase in C and U ewes, but did not affect LH-stimulated P4 secretion by luteal cells from any 
stage or nutritional group.  In rabbits, leptin decreased basal P4 secretion by luteal cells and it 
was suggested that leptin has a luteolytic role (Zerani et al. 2004).  Others have shown that leptin 
influence ovarian function including luteal function in women (Löffer et al., 2001), sows (Ruiz-
Cortés et al., 2003), and cows (Nicklin et al., 2007).  In fact, leptin may act as the critical link 
between adipose tissue and the reproductive system, indicating whether adequate energy reserves 
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are present for normal reproductive function (Moschos et al. 2002).  The leptin receptor is 
expressed on the bovine CL and leptin affected in vitro P4 secretion in bovine and equine luteal 
cells (Nicklin et al., 2007; Galvão et al., 2014).   
Changes in plasma leptin concentration has been associated with changes in P4 
concentration, reaching its peak during the luteal phase in women (Lugwig et al., 2000).  
However, in O ewes, leptin concentration was lower during the mid-luteal phase when plasma P4 
concentration is high (Kaminski et al. (2015).  In addition, Kaminski et al. (2015) demonstrated 
that in O ewes leptin and P4 concentrations were greater that in C or U ewes.  While it is evident 
that metabolic hormones can influence the production of steroidogenic hormones, further 
research is needed to explicate the relationship between metabolic state and luteal function. 
In the current study, adiponectin did not affect basal and LH-stimulated P4 secretion by 
ovine luteal cells.  It has been demonstrated that the adiponectin receptor 1 protein expression is 
greatest in early CL and that adiponectin plasma concentrations were significantly higher 
throughout the luteal phase than in the follicular phase, demonstrated its potential involvement in 
regulation of CL function in sows (Maleszka et al., 2014a).  Furthermore, inhibitory effects of 
adiponection on P4 secretion by porcine luteal cells in vitro have been reported (Maleszka et al., 
2014b).  Adiponectin is known to influence female reproduction including folliculogenesis, 
implantation (Dos Santos et al., 2012) and periovulatory changes (Palin et al., 2012).  However, 
the role of adiponectin in regulation of luteal function is rather unclear due to limited research in 
this area.  Our current results suggest that adiponectin is not involved in the regulation of P4 
secretion by luteal cells during the estrous cycle in ewes.   
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In summary, this study demonstrated that 1) nutritional plane affects ovulation rate in 
FSH-treated ewes; 2) DETA-NONOate decreased basal and LH-stimulated P4 secretion by luteal 
cells, 3) L-NAME increased basal and/or LH-stimulated P4 secretion by luteal cells and depends 
on stage of estrous cycle and nutritional plane, 4) Arg and adiponectin did not affect basal or LH-
stimulated P4 secretion, and 5) leptin increased basal P4 secretion by luteal cells from d5 from C 
and U ewes, but did not affect LH-stimulated P4 secretion.  Thus, we have supported previous 
reports that nutritional plane is critical for increasing ovulation rates, and have also demonstrated 
that the NO system and metabolic hormones play a role in modulating P4 secretion by ovine 
luteal cells during the estrous cycle in ewes fed different nutritional planes.  This study provides 
novel information since the effects of the NO system, Arg, and metabolic hormones on luteal cell 
function have yet to be studied in association with nutritional plane in any species.  The 
molecular pathway(s) of regulation in P4 secretion from luteal cells still requires further 
research.     
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CHAPTER 5: GENERAL CONCLUSIONS AND FUTURE DIRECTIONS 
 
 Proper ovarian function is critical for reproductive performance in pregnant and non-
pregnant females.  However, while nutrition (McEvoy et al., 1995; Wrenzycki et al., 2000; 
Kwong et al., 2000; Boland et al., 2001; Armstrong et al., 2001; Lozano et al., 2003; Grazul-
Bilska et al., 2012) and the NO system (Okuda et al., 1998; Skarzynski and Okuda, 2000; Bu et 
al., 2003; Tao et al., 2004) are reported to influence reproduction, very limited information exists 
regarding the associations between nutritional plane, the NO system, and their collective 
influences on ovarian function in sheep.   
Feeding non-pregnant sheep to achieve different planes of nutrition (i.e. overfeeding or 
underfeeding) for a prolonged period of time resulted in different body conditions, ovulation 
rates in both non-stimulated and FSH-treated ewes, angiogenic factor expression in luteal tissues, 
serum P4 concentrations, and oocyte function when compared to control fed ewes in our study.  
Overfeeding and underfeeding may be negatively influencing reproduction in females through 
fat accumulation or depletion, as we also observed altered lipid droplet accumulation in oocytes.  
Based on this information, further research is warranted to determine the underlying molecular 
mechanisms associated with varying plane of nutrition and reported changes of lipid content in 
oocytes.  In addition, research is needed to determine if lipid content is altered in earlier-stage 
oocytes (such as primordial, primary, and secondary oocytes) and, therefore has long-term 
effects on female reproduction, as we only investigated mature oocytes in the current study. 
 It has been reported that Arg supplementation to pregnant animals (through diet or 
injected intravenously) resulted in an increase in the number of live offspring born (Mateo et al., 
2007; Zeng et al., 2008; Luther et al., 2009), heavier lamb birth weights (De Boo et al., 2005; 
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McCoard et al., 2013), and prevents fetal growth restriction when supplemented to underfed 
mothers (Lassala et al., 2010).  Our current study was performed using non-pregnant animals, 
and therefore it provides novel information regarding the effects of Arg supplementation on 
ovarian function in animals fed different nutritional plane.  In vivo Arg supplementation to non-
pregnant ewes resulted in increased luteal vascularity and selected angiogenic factor expression 
in luteal tissue, but did not affect ovulation rate, CL weight, and P4 production.  Additional 
research regarding Arg and the NO system is necessary to determine additional potential benefits 
in non-pregnant females.  Because Arg supplementation was associated with increased 
vascularization (as noted by increased endothelial cell marker CD31), but did not lead to changes 
in production of P4, future research is needed to determine factors that may influence P4 
production and could, therefore, be utilized to increase reproductive efficiency.   
Supplementation of Arg during in vitro maturation and fertilization resulted in increased 
lipid droplet accumulation in oocytes and decreased cleavage rates after in vitro fertilization, 
respectively.  Future research explaining how the oocyte, as well as reproductive tissues, 
utilize(s) Arg may assist in elucidating why Arg supplementation to pregnant mothers is 
beneficial, while supplementation to non-pregnant females has limited effects. 
In Chapter 4, we reported that the NO system and metabolic hormones play a role in 
modulating P4 secretion by ovine luteal cells during the estrous cycle in ewes fed different 
nutritional planes.  The data provide novel information since the effects of the NO system, Arg, 
and metabolic hormones on luteal cell function have yet to be studied in association with 
nutritional plane in any species.  However, supplemental research regarding the molecular 
pathway(s) of regulation in P4 secretion from luteal cells is still required. 
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 In summary, these studies contribute to the knowledge of nutritional plane and the NO 
system and how they influence reproduction in female livestock.  The results obtained provide 
beneficial knowledge for future research regarding the improvement of reproductive efficiency 
in females, which could additionally assist producers considering therapeutic supplements for 
reproductively-sound livestock.   
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